KR101922598B1 - Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof - Google Patents

Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof Download PDF

Info

Publication number
KR101922598B1
KR101922598B1 KR1020160144478A KR20160144478A KR101922598B1 KR 101922598 B1 KR101922598 B1 KR 101922598B1 KR 1020160144478 A KR1020160144478 A KR 1020160144478A KR 20160144478 A KR20160144478 A KR 20160144478A KR 101922598 B1 KR101922598 B1 KR 101922598B1
Authority
KR
South Korea
Prior art keywords
mutation
probe
rnf213
primer
gene
Prior art date
Application number
KR1020160144478A
Other languages
Korean (ko)
Other versions
KR20180047774A (en
Inventor
기창석
임현숙
김유리
Original Assignee
사회복지법인 삼성생명공익재단
주식회사 바이오세움
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사회복지법인 삼성생명공익재단, 주식회사 바이오세움 filed Critical 사회복지법인 삼성생명공익재단
Priority to KR1020160144478A priority Critical patent/KR101922598B1/en
Publication of KR20180047774A publication Critical patent/KR20180047774A/en
Application granted granted Critical
Publication of KR101922598B1 publication Critical patent/KR101922598B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00Nucleic acid detection characterised by assay method
    • C12Q2561/113Real time assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10Detection mode being characterised by the assay principle
    • C12Q2565/101Interaction between at least two labels

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

RNF213 유전자의 돌연변이 검출용 프라이머 및 프로브를 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물, 키트 및 이를 이용하여 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법에 관한 것이다. 상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물을 이용하면 일반적인 염기서열분석 기술에 비하여 간단하면서도 정확하게 관련 질환의 원인 돌연변이를 검출할 수 있다.A kit for diagnosing diseases caused by mutation of c.14429G > A of RNF213 gene including primers and probes for mutation detection of RNF213 gene and a kit for diagnosing diseases caused by mutation of c.14429G >Gt; A < / RTI > mutation. Using a composition for diagnosing a disease caused by the mutation of c.14429G > A of the RNF213 gene, mutation of the cause of the related disease can be detected simply and accurately as compared with a general base sequence analysis technique.

Description

실시간 중합효소연쇄반응을 이용하여 RNF213 유전자의 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물 및 이의 이용{Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof}[0001] The present invention relates to a composition for diagnosing a disease caused by a mutation of RNF213 gene using real-time PCR, and to a use thereof,

RNF213 유전자의 돌연변이 검출용 프라이머 및 프로브를 포함하는 RNF213 유전자의 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물, 키트, 및 이를 이용하여 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법에 관한 것이다.A kit for diagnosing diseases caused by mutation of RNF213 gene including primers and probes for detecting mutation of RNF213 gene, and a kit for diagnosing diseases caused by mutation of RNF213 gene by real-time PCR And a method for providing information necessary for diagnosis.

모야모야병(moyamoya disease)은 양측 내경동맥 형성부전이라고도 하며, 특별한 이유 없이 뇌 속 특정 혈관 즉, 내경동맥의 끝부분이 막히는 만성 진행성 뇌혈관 질환을 말한다 뇌혈관 동맥 조영상에 따라 일본말로 "담배연기가 모락모락 올라가는 모양"의 뜻을 지닌 모야모야병으로 명명되었다. 일본의 경우 1990년까지 집계된 환자 수는 약 3,300명이며 매년 새로 발견되는 환자 수는 약 200명으로 알려져 있다. 세계에서 일본 다음으로는 한국과 중국에 이 질환이 많이 발생된다.Moyamoya disease is a chronic progressive cerebrovascular disease in which a specific blood vessel in the brain, that is, the end of the internal carotid artery, is occluded for no particular reason, referred to as bilateral carotid artery anomalies. According to the cerebral angiogram, It was named as "Moyamoya disease" with the meaning of "the shape of the marmalade rising." In Japan, the number of patients collected by 1990 is about 3,300, and the number of patients newly discovered every year is about 200. In Japan, the disease is more common in Korea and China than in the world.

이 질병은 전반적인 정확한 발병 원리나 원인은 밝혀지지 않았으나, 최근 RNF213 유전자의 c.14429G>A (p.Arg4810Lys) 변이가 중요한 유전적 요인으로 밝혀졌다(J Hum Genet 2011; 56:34-40). 일본인 모야모야병 환자의 경우 가족성 환자의 약 95%와 산발성 환자의 약 73%에서 이 변이가 발견되었다. 이 변이는 정상 일본인의 약 1.4%에서 발견되었으며, 따라서 RNF213 c.14429G>A (p.Arg4810Lys) 변이를 가지고 있는 사람에서 모야모야병의 Odds Ratio는 약 190.8 (95% Confidence Interval 71.7-507.9)로 추정되었다. 후속 연구에서 중국인과 한국인 모야모야병 환자에서도 이 변이는 모야모야병의 중요한 유전적 원인임이 확인되었다(PLoS One 2011; 6:e22542, PLoS One 2015;10:e0130663, J Neurosurg 2016;124:1221-1227).Although the exact cause of the disease and its cause have not been elucidated, the recent mutation in the RNF213 gene c.14429G> A (p.Arg4810Lys) has been identified as an important genetic factor (J Hum Genet 2011; 56: 34-40). About 95% of Japanese patients with familial moyamoya disease and 73% of sporadic patients had this mutation. This mutation was found in approximately 1.4% of normal Japanese subjects, and therefore the odds ratio of moyamoya disease was approximately 190.8 (95% Confidence Interval 71.7-507.9) in patients with RNF213 c.14429G> A (p.Arg4810Lys) mutation Respectively. In a follow-up study, this mutation was also found to be an important genetic cause of moyamoya disease in Chinese and Korean patients with Moyamoya disease (PLoS One 2011; 6: e22542; PLoS One 2015; 10: e0130663; J Neurosurg 2016; 124: 1221- 1227).

또한, 최근에는 RNF213 유전자의 c.14429G>A (p.Arg4810Lys) 변이가 모야모야병 뿐만 아니라 뇌혈관 협착증(intracranial stenosis), 뇌혈관 동맥경화증(intracranial atherosclerosis), 신장동맥 협착증(rental artery stenosis), 폐동맥 혈관병증(pulmonary vasculopathy) 등 다양한 질환과 관련되었음이 알려졌다(PLoS One 2015;10:e0130663, PLoS One 2016;11:e0156607, Am J Med Genet 2016;170:2453-2456).In addition, recently, the mutant c.14429G> A (p.Arg4810Lys) of the RNF213 gene has not only moyamoya disease but also intracranial stenosis, intracranial atherosclerosis, renal artery stenosis, (PLoS One 2015; 10: e0130663; PLoS One 2016; 11: e0156607; Am J Med Genet 2016; 170: 2453-2456).

이에 본 발명자들은 모야모야병 및 관련 질환의 유전적 요인으로서 RNF213 유전자의 돌연변이를 효과적으로 검출하기 위한 방법에 대해 연구를 수행하여 본 발명을 완성하였다.Therefore, the present inventors completed the present invention by carrying out studies on a method for effectively detecting the mutation of RNF213 gene as a genetic factor of Moyamoya disease and related diseases.

J Hum Genet 2011; 56:34-40. J Hum Genet 2011; 56: 34-40. PLoS One 2011; 6:e22542.  PLoS One 2011; 6: e22542. PLoS One 2015; 10:e0130663.  PLoS One 2015; 10: e0130663. J Neurosurg 2016; 124:1221-1227. J Neurosurg 2016; 124: 1221-1227. PLoS One 2016; 11:e0156607.  PLoS One 2016; 11: e0156607. Am J Med Genet 2016; 170:2453-2456. Am J Med Genet 2016; 170: 2453-2456.

일 양상은 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 및 프로브를 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물을 제공한다.One aspect provides a composition for diagnosing a disease caused by a c.14429G > A mutation of the RNF213 gene including primers and probes for detecting c.14429G > A mutation of the RNF213 gene.

다른 양상은 상기 조성물을 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 키트를 제공한다.Another aspect provides a kit for diagnosing a disease caused by the c.14429G > A mutation of the RNF213 gene comprising the composition.

다른 양상은 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법을 제공한다.Another aspect provides a method of providing information necessary for the diagnosis of a disease caused by the c.14429G > A mutation of the RNF213 gene by real-time PCR.

일 양상은 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 및 프로브를 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물로서,One aspect is a composition for diagnosing a disease caused by a mutation c.14429G > A of RNF213 gene including primers and probes for detecting c.14429G > A mutation of RNF213 gene,

상기 프라이머는 서열번호 1 및 2의 프라이머 쌍이며,The primers are the primer pairs of SEQ ID NOS: 1 and 2,

상기 프로브는 서열번호 3 및 4의 프로브 쌍이며,Wherein said probe is a probe pair of SEQ ID NOS: 3 and 4,

상기 프로브는 5'-말단에 형광물질로 표지되고, 3'-말단에 소광물질로 표지되며,The probe is labeled with a fluorescent substance at the 5'-end, a small mineral substance at the 3'-end,

상기 프로브 쌍은 RNF213 유전자의 야생형에 결합하는 야생형 검출용 프로브와 RNF213 유전자의 돌연변이에 결합하는 돌연변이 검출용 프로브로 이루어진 것인 조성물을 제공한다.Wherein the probe pair comprises a wild type detecting probe which binds to the wild type of the RNF213 gene and a mutation detecting probe which binds to the mutation of the RNF213 gene.

상기 RNF213 유전자의 돌연변이는 하기와 같이 정의된다:The mutation of the RNF213 gene is defined as follows:

RNF213(Ring finger protein 213) 유전자의 돌연변이는 서열번호 5로 표시되는 RNF213 유전자(NCBI Accession no. NM_001256071)에서 코딩 서열(coding sequence: CDS)을 기준으로 표시된다. 서열번호 5에서 151번 내지 15774번 위치의 뉴클레오티드 서열은 RNF213 유전자의 코딩 서열(CDS)에 해당한다. 번역 개시 코돈은 ATG의 A를 뉴클레오티드 +1로 표시하며, 서열번호 5에서 151번 위치의 A가 뉴클레오티드 +1로 표시된다.The mutation of the RNF213 (Ring finger protein 213) gene is expressed based on the coding sequence (CDS) in the RNF213 gene (NCBI Accession No. NM_001256071) shown in SEQ ID NO: 5. The nucleotide sequence from position 151 to position 15774 in SEQ ID NO: 5 corresponds to the coding sequence (CDS) of the RNF213 gene. The translation initiation codon represents ATG A at nucleotide +1 and A at position 151 in SEQ ID NO: 5 is represented by nucleotide +1.

치환(substitution) 돌연변이는 기호 ">"를 표시하여 기재하며, ">" 앞의 문자는 정상인 RNF213 유전자의 뉴클레오티드이며, ">" 뒤의 문자는 돌연변이 RNF213 유전자의 뉴클레오티드를 의미한다.The substitution mutation is indicated by the symbol ">", the letter preceding the ">" is the nucleotide of the normal RNF213 gene, and the letter after ">" is the nucleotide of the mutant RNF213 gene.

돌연변이 "c.14429G>A"는 서열번호 5의 뉴클레오티드 서열의 코딩 서열(CDS)에서 14429번째 위치의 G가 A로 치환된 것을 의미한다.The mutation " c.14429G > A " means that G at position 14429 was substituted with A in the coding sequence (CDS) of the nucleotide sequence of SEQ ID NO:

상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병은 예를 들어, 모야모야병, 뇌혈관 협착증(intracranial stenosis), 뇌혈관 동맥경화증(intracranial atherosclerosis), 신장동맥 협착증(rental artery stenosis), 폐동맥 혈관병증(pulmonary vasculopathy) 등일 수 있으나, 이에 한정되지 않는다(PLoS One 2015;10:e0130663, PLoS One 2016;11:e0156607, Am J Med Genet 2016;170:2453-2456).Diseases caused by the c.14429G > A mutation of the RNF213 gene include, for example, diseases such as Moyamoya disease, intracranial stenosis, intracranial atherosclerosis, renal artery stenosis, (PLoS One 2015; 10: e0130663; PLoS One 2016; 11: e0156607; Am J Med Genet 2016; 170: 2453-2456).

용어, "프라이머(primer)"는 중합효소연쇄반응에서 증폭되는 표적 핵산 부위의 5' 말단 서열 또는 3' 말단 서열에 각각 상보적이고, 적합한 온도에서 중합효소연쇄반응액 중 주형-지시 핵산의 중합효소반응의 개시점으로 작용할 수 있는 단일-가닥 올리고뉴클레오티드를 의미한다. 프라이머의 적합한 길이는 반응 온도와 프라이머의 용도 등의 인자에 따라 정해지나, 일반적으로 15 내지 30개의 뉴클레오티드로 이루어진다.The term " primer " refers to a nucleic acid sequence complementary to the 5 ' end or the 3 ' end sequence of a target nucleic acid region amplified in a polymerase chain reaction, Strand < / RTI > oligonucleotide that can serve as the starting point of the reaction. The suitable length of the primer is determined depending on factors such as the reaction temperature and the use of the primer, but is generally 15 to 30 nucleotides.

용어, "프로브(probe)"는 표적 서열에 상보적인 서열을 포함하는, 단일가닥 핵산 분자를 의미한다. 프로브는 혼성화 특이성이 손상되지 않는 범위 내에서 변형될 수 있다. 예를 들면, 리포터 형광물질 또는 소광물질(quencher)이 프로브의 말단에 부착될 수 있다.The term " probe " refers to a single-stranded nucleic acid molecule comprising a sequence complementary to a target sequence. Probes can be modified to the extent that the hybridization specificity is not impaired. For example, a reporter fluorescent substance or a quencher may be attached to the end of the probe.

상기 프로브는 5'-말단에 형광물질로 표지되고, 3'-말단에 소광물질로 표지되어 실시간 중합효소연쇄반응에서 사용할 수 있다.The probe may be labeled at the 5'-end with a fluorescent substance and at the 3'-end with a small mineral substance and used in a real-time PCR.

상기 형광물질은 6-FAM(6-Carboxyfluorescein), VIC, TET(2',7'-dichloro-6-carboxy-4,7-dichlorofluorescein), 6-JOE(6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein), HEX(2',4',5',7'-tetrachloro-6-carboxy-4,7-dichlorofluorescein), Cy3(Cyanine 3), 또는 Cy5일 수 있으나, 이에 한정되지 않는다.The fluorescent material may be 6-Carboxyfluorescein, VIC, TET (2 ', 7'-dichloro-6-carboxy-4,7-dichlorofluorescein), 6-JOE (6-carboxy- dichloro-2 ', 7'-dimethoxyfluorescein, HEX (2', 4 ', 5', 7'- tetrachloro-6-carboxy-4,7-dichlorofluorescein), Cy3 (Cyanine 3) But is not limited thereto.

상기 VIC는 비슷한 파장대의 JOE 또는 HEX에 비해 강도(intensity)가 약 2~3배 높으므로, 형광물질로 VIC를 사용하는 경우 검출 민감도가 더욱 우수할 수 있다.Since the intensity of VIC is about two to three times higher than that of JOE or HEX of similar wavelength, detection sensitivity can be more excellent when VIC is used as a fluorescent material.

상기 소광물질은 MGB-NFQ, 6-TAMRA(6-carboxytetramethylrhodamine), BHQ(Black Hole Quencher)-1, BHQ-2, BH3-3, 또는 ROX(carboxy-X-rhodamine)일 수 있으나, 이에 한정되지 않는다.The minerals may be MGB-NFQ, 6-carboxytetramethylrhodamine, BHQ-2, BH3-3 or ROX (carboxy-X-rhodamine) Do not.

상기 MGB-NFQ는 MGB(Minor Groove Binder)와 NFQ(Non-Fluorescent Quencher)의 두가지 유닛으로 구성되어 있다. MGB는 프로브의 Tm(melting temperature)를 높여주고 주형과 프로브의 결합력을 향상시키는 역할을 할 수 있기 때문에, 길이가 짧으면서 특이도가 높은 프로브의 제작이 가능하다. 또한, TAMRA 또는 ROX가 배경 형광을 발생시키는 것과 달리, NFQ는 형광을 띠지 않기 때문에 배경 형광을 발생시키지 않는다는 장점이 있다. The MGB-NFQ is composed of two units, MGB (Minor Groove Binder) and NFQ (Non-Fluorescent Quencher). MGB can increase the melting temperature of the probe and improve the bonding strength between the template and the probe. Therefore, it is possible to manufacture a probe having a short length and high specificity. Also, unlike TAMRA or ROX, which generates background fluorescence, NFQ has the advantage of not generating background fluorescence since it does not fluoresce.

상기 서열번호 3의 프로브는 RNF213 유전자의 돌연변이에 결합하는 돌연변이 검출용 프로브이다.The probe of SEQ ID NO: 3 is a mutation detection probe that binds to a mutation of RNF213 gene.

상기 서열번호 4의 프로브는 RNF213 유전자의 야생형에 결합하는 야생형 검출용 프로브이다.The probe of SEQ ID NO: 4 is a wild type detection probe that binds to the wild type of RNF213 gene.

상기 야생형 검출용 프로브와 돌연변이 검출용 프로브는 상이한 형광물질에 의해 표지될 수 있다. 야생형 검출용 프로브의 형광물질에 의한 신호와 돌연변이 검출용 프로브의 형광물질에 의한 신호가 구별되므로, 야생형 검출용 프로브의 신호가 양성이면 야생형, 돌연변이 검출용 프로브의 신호가 양성이면 돌연변이, 양자 모두의 신호가 양성이면 야생형과 돌연변이의 이형접합형인 것으로 판단할 수 있다.The wild type detecting probe and the mutation detecting probe may be labeled with different fluorescent materials. Since the signal by the fluorescent substance of the wild type detection probe and the signal by the fluorescent substance of the probe for mutation detection are distinguished, if the signal of the wild type detection probe is positive, the wild type, if the signal of the mutation detection probe is positive, If the signal is positive, it can be judged to be a heterozygous type of wild type and mutation.

상기 RNF213 유전자의 돌연변이는 실시간 중합효소연쇄반응에 의해 검출된다.Mutations of the RNF213 gene are detected by real-time PCR.

상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물은 실시간 중합효소연쇄반응의 수행을 위해 필요한 dNTP 혼합물(dATP, dCTP, dGTP, dTTP), DNA 중합효소, 및 완충 용액을 더 포함할 수 있다.The composition for diagnosing a disease caused by the mutation of c.14429G> A of the RNF213 gene comprises a dNTP mixture (dATP, dCTP, dGTP, dTTP), a DNA polymerase, and a buffer solution As shown in FIG.

실시간 중합효소연쇄반응은 표적 핵산의 증폭과 측정을 동시에 진행한다. 중합효소연쇄반응에 의한 증폭 산물로부터 발생하는 형광의 강도를 실시간으로 측정하므로, 전통적인 중합효소연쇄반응에 비해 신속하게 민감하게 결과를 확인할 수 있다. 또한, 증폭 산물의 분석을 위한 전기영동이나 서열결정과 같은 추가적인 단계를 필요로 하지 않는다.Real-time polymerase chain reaction simultaneously amplifies and measures the target nucleic acid. Since the intensity of fluorescence generated from amplification products by polymerase chain reaction is measured in real time, the results can be confirmed more quickly than conventional polymerase chain reaction. It also does not require additional steps such as electrophoresis or sequencing for the analysis of amplification products.

상기 실시간 중합효소연쇄반응은 본 발명이 속하는 기술분야에서 알려진 통상적인 조건에서 수행될 수 있고, 실시간 중합효소연쇄반응의 진행 중 어닐링 및 연장 단계에서 형광물질이 부착된 프로브로부터의 형광을 측정할 수 있다.The real-time PCR can be performed under the conventional conditions known in the art, and the fluorescence from the probe with the fluorescent substance can be measured in the annealing and extension steps during the progress of the real-time PCR have.

예시적으로, 상기 야생형 검출용 프로브는 5' 말단에 FAM으로 표지되고, 돌연변이 검출용 프로브는 VIC로 표지될 수 있다. 프로브가 표적 서열에 혼성화되면, 3' 말단에 존재하는 소광물질의 작용에 의해 5' 말단의 형광물질이 형광을 방출하지 못한다. 그러나, 중합효소연쇄반응의 연장 단계에서, Taq 중합효소와 같은 열안정성 DNA 중합효소의 5'→3' 엑소뉴클레아제 활성에 의해 주형에 혼성화된 프로브가 분해되고, 5' 말단의 형광물질이 프로브로부터 분리되어 소광물질에 의한 형광억제로부터 벗어나서 형광을 방출한다. 따라서, FAM에 의한 형광 신호는 야생형 유전자형을 의미하고, VIC에 의한 형광 신호는 돌연변이 유전자형을 의미할 수 있다. 두 신호가 동시에 검출되는 경우는 야생형과 돌연변이가 접합된 이형접합형을 의미할 수 있다.Illustratively, the wild type detecting probe may be labeled with FAM at the 5 'end, and the mutation detecting probe may be labeled with VIC. When the probe is hybridized to the target sequence, the fluorescent substance at the 5 'end does not emit fluorescence due to the action of the minerals present at the 3' end. However, in the prolongation of the polymerase chain reaction, the probe hybridized to the template is degraded by the 5 'to 3' exonuclease activity of the thermostable DNA polymerase such as Taq polymerase, and the fluorescent substance at the 5 ' It separates from the probe and emits fluorescence away from the fluorescence inhibition by the minerals. Therefore, the fluorescence signal by FAM means a wild type genotype, and the fluorescence signal by VIC can mean a mutant genotype. When two signals are detected at the same time, it may mean a heterozygous type in which wild type and mutation are joined.

다른 양상은 상기 조성물을 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 키트를 제공한다.Another aspect provides a kit for diagnosing a disease caused by the c.14429G > A mutation of the RNF213 gene comprising the composition.

구체적으로, 상기 키트는 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 및 프로브를 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 키트로서,Specifically, the kit is a kit for diagnosing a disease caused by mutation c.14429G> A of the RNF213 gene including a primer and a probe for detecting c.14429G> A mutation of the RNF213 gene,

상기 프라이머는 서열번호 1 및 2의 프라이머 쌍이며,The primers are the primer pairs of SEQ ID NOS: 1 and 2,

상기 프로브는 서열번호 3 및 4의 프로브 쌍이며,Wherein said probe is a probe pair of SEQ ID NOS: 3 and 4,

상기 프로브는 5'-말단에 형광물질로 표지되고, 3'-말단에 소광물질로 표지되며,The probe is labeled with a fluorescent substance at the 5'-end, a small mineral substance at the 3'-end,

상기 프로브 쌍은 RNF213 유전자의 야생형에 결합하는 야생형 검출용 프로브와 RNF213 유전자의 돌연변이에 결합하는 돌연변이 검출용 프로브로 이루어진 것인 키트일 수 있다.The probe pair may be a kit comprising a wild type detecting probe which binds to the wild type of the RNF213 gene and a mutation detecting probe which binds to the mutation of the RNF213 gene.

상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병은 예를 들어, 모야모야병, 뇌혈관 협착증, 뇌혈관 동맥경화증, 신장동맥 협착증, 폐동맥 혈관병증 등일 수 있으나, 이에 한정되지 않는다.The disease causing the c.14429G > A mutation of the RNF213 gene may be, for example, Moyamoya disease, cerebrovascular stenosis, cerebrovascular arteriosclerosis, renal artery stenosis, pulmonary vascular disease, and the like.

상기 키트는 실시간 중합효소연쇄반응 키트일 수 있다.The kit may be a real-time polymerase chain reaction kit.

상기 키트는 실시간 중합효소연쇄반응의 수행을 위해 필요한 1종 이상의 다른 구성성분 조성물, 용액 또는 장치가 포함될 수 있다. 구체적으로, 상기 키트는 dNTP 혼합물(dATP, dCTP, dGTP, dTTP), DNA 중합효소, 완충 용액 등을 더 포함할 수 있다. 또한, 상기 키트는 테스트 튜브 또는 다른 적절한 컨테이너 등을 더 포함할 수 있다.The kit may comprise one or more other component compositions, solutions or devices needed for the performance of a real-time polymerase chain reaction. Specifically, the kit may further comprise a dNTP mixture (dATP, dCTP, dGTP, dTTP), a DNA polymerase, a buffer solution and the like. In addition, the kit may further comprise a test tube or other suitable container or the like.

다른 양상은 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법으로서,Another aspect is a method for providing information necessary for diagnosis of diseases caused by mutation of c.14429G > A of RNF213 gene by real-time PCR,

검체로부터 분리된 DNA를 주형으로, 서열번호 1 및 2의 프라이머 쌍, 및 서열번호 3 및 4의 프로브 쌍을 이용하여 실시간 중합효소연쇄반응을 수행하는 단계; 및Performing a real-time PCR using the DNA isolated from the sample as a template, the pair of primers of SEQ ID NOS: 1 and 2, and the pairs of probes of SEQ ID NOS: 3 and 4; And

RNF213 유전자의 c.14429G>A 돌연변이 부위의 유전자형을 확인하는 단계를 포함하고,Confirming the genotype of the c.14429G > A mutation site of the RNF213 gene,

상기 프로브는 5'-말단에 형광물질로 표지되고, 3'-말단에 소광물질로 표지되며,The probe is labeled with a fluorescent substance at the 5'-end, a small mineral substance at the 3'-end,

상기 프로브 쌍은 RNF213 유전자의 야생형에 결합하는 야생형 검출용 프로브와 RNF213 유전자의 돌연변이에 결합하는 돌연변이 검출용 프로브로 이루어진 것인 방법을 제공한다.Wherein the probe pair comprises a wild type detecting probe which binds to the wild type of the RNF213 gene and a mutation detecting probe which binds to the mutation of the RNF213 gene.

상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병은 예를 들어, 모야모야병, 뇌혈관 협착증, 뇌혈관 동맥경화증, 신장동맥 협착증, 폐동맥 혈관병증 등일 수 있으나, 이에 한정되지 않는다.The disease causing the c.14429G > A mutation of the RNF213 gene may be, for example, Moyamoya disease, cerebrovascular stenosis, cerebrovascular arteriosclerosis, renal artery stenosis, pulmonary vascular disease, and the like.

상기 RNF213 돌연변이 부위의 유전자형을 확인하는 단계에서 상기 RNF213 돌연변이 부위에 대한 야생형 검출용 프로브 신호와 돌연변이 검출용 프로브 신호의 동시 검출은 상기 검체가 이형접합자(heterozygote)라는 것을 나타낼 수 있다.Simultaneous detection of the wild type detection probe signal and the mutation detection probe signal for the RNF213 mutation site in the step of identifying the genotype of the RNF213 mutation site may indicate that the specimen is a heterozygote.

상기 형광물질은 6-FAM, VIC, TET, 6-JOE, HEX, Cy3, 또는 Cy5일 수 있으나, 이에 한정하지 않는다.The fluorescent material may be 6-FAM, VIC, TET, 6-JOE, HEX, Cy3, or Cy5, but is not limited thereto.

상기 소광물질은 MGB-NFQ, 6-TAMRA, BHQ-1, BHQ-2, BH3-3, 또는 ROX일 수 있으나, 이에 한정하지 않는다.The minerals may be, but not limited to, MGB-NFQ, 6-TAMRA, BHQ-1, BHQ-2, BH3-3 or ROX.

상기 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법은 검체로부터 분리된 DNA를 주형으로, 서열번호 1 및 2의 프라이머 쌍, 및 서열번호 3 및 4의 프로브 쌍을 이용하여 실시간 중합효소연쇄반응을 수행하는 단계를 포함할 수 있다.A method for providing information necessary for diagnosis of a disease caused by the c.14429G > A mutation of the RNF213 gene by the real-time PCR is as follows: a DNA isolated from a specimen is used as a template, a pair of primers of SEQ ID NOS: 1 and 2, And performing a real-time PCR using the probe pairs of SEQ ID NOS: 3 and 4.

상기 "진단"은 병리 상태의 존재 또는 특징을 확인하는 것을 의미한다. 따라서, 상기 "RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단"이란 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 발병 여부 또는 발병 가능성을 확인하거나 발병의 위험을 예측하는 것을 의미할 수 있다.Said " diagnosis " means identifying the presence or characteristic of a pathological condition. Therefore, the above-mentioned " diagnosis of a disease caused by mutation c.14429G > of the RNF213 gene " refers to the diagnosis of the disease or the possibility of the disease caused by mutation c.14429G> A of the RNF213 gene, It can mean to do.

상기 "검체"란 검사, 분석 등에 사용되는 생물이나 물질을 의미하는 것으로서, RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 발병 여부 또는 발병 가능성을 확인하거나 발병 위험도를 예측하거나 보인자 여부를 확인하고자 하는 개체로부터 분리한 시료일 수 있다. 상기 검체는 개체로부터 분리된 조직, 세포, 전혈, 혈청, 혈장, 타액, 객담, 뇌척수액 또는 뇨와 같은 시료 등을 포함할 수 있으나, 이에 한정하지 않는다.The term " sample " means a living organism or substance used for inspection, analysis, and the like, and it is possible to confirm whether or not the disease caused by mutation c.14429G> A of RNF213 gene is present or not, May be a sample separated from an object to be identified. The sample may include, but is not limited to, tissues, cells, whole blood, serum, plasma, saliva, sputum, cerebrospinal fluid or urine separated from an individual.

실시간 중합효소연쇄반응은 본 발명이 속하는 기술분야에서 알려진 통상적인 조건에서 수행될 수 있다. 실시간 중합효소연쇄반응의 진행 중 어닐링 및 연장 단계에서 형광물질이 부착된 프로브로부터의 형광을 측정한다. 형광의 측정 및 분석은 실시간 중합효소연쇄반응에서 발생되는 형광을 분석하는 소프트웨어를 이용하여 용이하게 수행될 수 있다.Real-time polymerase chain reaction can be carried out under conventional conditions known in the art. The fluorescence from the probe with the fluorescent material is measured in the annealing and extension steps during the course of the real-time PCR. Measurement and analysis of fluorescence can be easily performed using software for analyzing fluorescence generated in real-time PCR.

상기 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법은 RNF213 유전자의 c.14429G>A 돌연변이 부위의 유전자형을 확인하는 단계를 포함할 수 있다.A method for providing information necessary for diagnosis of a disease caused by the c.14429G > A mutation of the RNF213 gene by the real-time PCR reaction includes a step of confirming the genotype of the c.14429G > A mutation site of the RNF213 gene can do.

상기 RNF213 돌연변이 부위의 유전자형을 확인하는 단계에서 실시간 중합효소연쇄반응은 각 RNF213 돌연변이 부위에 대해, 유전자형이 확인된 야생형 유전자 및 돌연변이형 유전자를 대조군으로 포함할 수 있다.In the step of confirming the genotype of the RNF213 mutation site, the real-time PCR may include a wild type gene and a mutant type gene having a confirmed genotype for each RNF213 mutation site as a control group.

상기 야생형 검출용 프로브와 돌연변이 검출용 프로브는 상이한 형광물질에 의해 표지될 수 있다. RNF213 돌연변이 부위의 유전자형은 야생형 검출용 프로브와 돌연변이 검출용 프로브의 형광 신호 검출에 의해 판단된다. 야생형 검출용 프로브의 형광 신호만 검출되는 경우, 해당 검체는 그 돌연변이 부위에 돌연변이를 갖지 않는 야생형, 즉, 정상이라는 것을 의미하고, 돌연변이 검출용 프로브의 형광 신호만 검출되는 경우, 이는 그 돌연변이의 동형접합형의 존재 즉, 모야모야병 또는 관련 질환 환자일 가능성이 높다는 것을 의미하며, 야생형 검출용 프로브와 돌연변이 검출용 프로브의 형광 신호가 모두 검출되는 경우, 이는 야생형과 돌연변이 모두가 존재하는 이형접합형을 갖는다는 것을 의미한다.The wild type detecting probe and the mutation detecting probe may be labeled with different fluorescent materials. The genotype of the RNF213 mutation site is determined by the detection of the fluorescent signal of the wild-type detection probe and the mutation detection probe. When only the fluorescent signal of the wild type detecting probe is detected, it means that the specimen is a wild type having no mutation at its mutation site, that is, normal. When only the fluorescent signal of the mutation detecting probe is detected, It means that there is a high possibility that the presence of the junction type, that is, the patient with moyamoya disease or related disease, and when both the wild type detection probe and the mutation detection probe fluorescence signal are detected, this means that the wild type and heterozygous type . ≪ / RTI >

일 양상에 따른 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물을 이용하면 일반적인 염기서열분석 기술에 비하여 간단하면서도 정확하게 상기 돌연변이를 원인으로 하는 질병의 원인 돌연변이를 검출할 수 있다.The use of a composition for diagnosing a disease caused by a mutation of c.14429G > A of the RNF213 gene according to one aspect of the present invention can detect a causative mutation of a disease caused by the mutation simply and accurately as compared with a general base sequence analysis technique have.

또한, 일 양상에 따른 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법을 이용하면 상기 질병의 원인 유전자에 대한 야생형, 돌연변이형 또는 이형접합형을 간편하게 확인할 수 있다.Further, by using a method of providing information necessary for diagnosis of a disease caused by mutation of c.14429G > A of RNF213 gene according to one aspect, it is possible to easily identify wild type, mutant type or heterozygous type for the causative gene of the disease .

도 1은 RNF213 유전자의 돌연변이 c.14429G>A를 검출하기 위한 프라이머 및 대립유전자 특이적 프로브 시스템의 작용 원리를 나타낸 도면이다.
도 2는 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 쌍 및 프로브 쌍을 이용하여 야생형 대조군에 대한 실시간 중합효소연쇄반응을 수행한 결과이다.
도 3은 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 쌍 및 프로브 쌍을 이용하여 돌연변이형 대조군에 대한 실시간 중합효소연쇄반응을 수행한 결과이다.
도 4는 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 쌍 및 프로브 쌍을 이용하여 헤테로형 대조군에 대한 실시간 중합효소연쇄반응을 수행한 결과이다.
도 5는 정상인 105명에 대하여 실시간 PCR과 염기서열분석을 수행하여 결정된 RNF213 c.14429G>A 돌연변이 부위의 유전자형 분석 결과이다.
도 6은 정상인 105명에 대하여 실시간 PCR을 수행하여 4건의 이형접합성(heterozygosity)을 확인한 결과이다.
도 7은 정상인 105명 중 4명의 이형접합성 검체 즉, #16, #19, #23 및 #43에 대한 실시간 PCR 및 염기서열분석 결과이다.
도 8은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F1 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 9는 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F2 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 10은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F2 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 11은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F3 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 12는 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F4 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 13은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F5 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 14는 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F6 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 15는 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F6 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다.
도 16은 구체적인 서열이 다른 다양한 조합의 프라이머 및 프로브를 사용하여 음성 검체에 대해 실시간 중합효소연쇄반응을 수행한 결과이다.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a diagram showing the principle of operation of primer and allele-specific probe system for detecting mutation c.14429G> A of RNF213 gene.
FIG. 2 shows results of real-time PCR for the wild-type control using primer pair and probe pair for detecting c.14429G> A mutation of RNF213 gene.
FIG. 3 shows results of real-time PCR for the mutant control group using primer pairs and probe pairs for detecting c.14429G> A mutation of RNF213 gene.
FIG. 4 shows the result of real-time PCR for the heterozygous control group using primer pair and probe pair for detecting c.14429G> A mutation of RNF213 gene.
FIG. 5 is a result of genotyping analysis of RNF213 c.14429G > A mutation site determined by real-time PCR and nucleotide sequence analysis for 105 healthy individuals.
FIG. 6 shows the result of confirming four heterozygosity by performing real-time PCR on 105 normal subjects.
FIG. 7 shows real-time PCR and nucleotide sequence analysis results for four heterozygous samples of # 105, that is, # 16, # 19, # 23 and # 43.
Fig. 8 shows results of real-time PCR using F1 primer, R1 primer and ZEN probe to detect RNF213 c.14429G > A mutation.
Fig. 9 shows results of real-time PCR using F2 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G > A mutation.
FIG. 10 shows results of real-time PCR using F2 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G> A mutation.
Figure 11 shows the result of real-time PCR using F3 primer, R1 primer and ZEN probe to detect RNF213 c.14429G > A mutation.
FIG. 12 shows results of real-time PCR using F4 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G> A mutation.
Fig. 13 shows results of real-time PCR using F5 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G > A mutation.
Fig. 14 shows the result of real-time PCR using F6 primer, R1 primer and ZEN probe to detect RNF213 c.14429G > A mutation.
Fig. 15 shows the result of real-time PCR using F6 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G > A mutation.
16 is a result of performing a real-time PCR on negative samples using various combinations of primers and probes having different sequences.

이하 본 발명을 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples. However, these examples are for illustrative purposes only, and the scope of the present invention is not limited to these examples.

실시예1. RNF213 유전자 돌연변이 검출용 프라이머 및 프로브 제작Example 1. Preparation of primers and probes for RNF213 gene mutation detection

서열번호 5의 RNF213 유전자(NCBI accession number: NM_001256071)의 돌연변이는 모야모야병, 뇌혈관 협착증, 뇌혈관 동맥경화증, 신장동맥 협착증, 폐동맥 혈관병증 등을 유발하는 것으로 알려져 있다. 따라서, RNF213 유전자의 돌연변이 c.14429G>A(p.R4810K)를 검출하기 위해 이용할 수 있는 프라이머 및 프로브를 제작하였다.Mutations in the RNF213 gene (NCBI accession number: NM_001256071) of SEQ ID NO: 5 are known to cause Moyamoya disease, cerebrovascular stenosis, cerebrovascular atherosclerosis, renal artery stenosis, pulmonary vascular disease and the like. Therefore, primers and probes that can be used to detect the mutation c.14429G > A (p.R4810K) of the RNF213 gene were prepared.

RNF213 유전자의 서열을 바탕으로, Primer Expres 3.0.1을 이용하여 c.14429G>A 돌연변이 부위를 증폭시킬 수 있는 프라이머 쌍을 설계하였다. 또한, c.14429G>A 돌연변이 부위의 야생형과 돌연변이형에 완벽하게 결합하는 프로브를 제작하였다. 각 프로브의 5' 말단에는 형광물질을 표지하였고, 3' 말단에는 형광을 내지 못하도록 하는 소광물질(quencher)을 표지하였다. 이때 변이가 있는 유전자 단편과 결합하는 프로브는 형광물질로 VIC를 표지하였고, 변이가 없는 야생형 유전자 단편과 결합하는 프로브는 형광물질로 FAM을 표지하였다. 프라이머의 제작은 코스모진텍(한국)에 의뢰하였으며, 프로브의 제작은 Life Technologies(미국)에 의뢰하였다. 하기 표 1에 RNF213 c.14429G>A 돌연변이 부위를 증폭하는 프라이머 쌍, 및 야생형 및 돌연변이형을 검출하는 프로브를 나타내었다. 도 1은 RNF213 유전자의 돌연변이 c.14429G>A를 검출하기 위한 프라이머 및 대립유전자 특이적 프로브 시스템의 작용 원리를 나타낸 도면이다.Based on the sequence of the RNF213 gene, Primer Expres 3.0.1 was used to design a primer pair capable of amplifying the c.14429G> A mutation site. In addition, probes were prepared which perfectly bound to the wild type and mutant forms of the c.14429G > A mutant site. A fluorescent substance was labeled at the 5 'end of each probe, and a quencher was labeled at the 3' end to prevent fluorescence. At this time, the probe binding to the mutated gene fragment was labeled with VIC as a fluorescent substance, and the probe binding with the wild type gene fragment without mutation was labeled with FAM as a fluorescent substance . Production of the primer was commissioned by Cosmojin Tech (Korea), and production of the probe was commissioned by Life Technologies (USA). The primer pair amplifying the RNF213 c.14429G > A mutation site and the probe for detecting the wild type and the mutant type are shown in Table 1 below. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a diagram showing the principle of operation of primer and allele-specific probe system for detecting mutation c.14429G> A of RNF213 gene.

유형type 서열번호SEQ ID NO: 명칭designation 서열order 정방향 프라이머Forward primer 1One RNF_MGB F1RNF_MGB F1 5' AGAACGTCCAGCAAGTTGAATACA 3' 5 'AGAACGTCCAGCAAGTTGAATACA 3' 역방향 프라이머Reverse primer 22 RNF_MGB R1RNF_MGB R1 5' TTTCGAACCGCCAAATGC 3' 5 'TTTCGAACCGCCAAATGC 3' 돌연변이형 검출용 프로브The mutation detection probe 33 RNF213(A) probeRNF213 (A) probe (VIC)5'CTCCATCAAAGGCT 3'(MGB-NFQ)(VIC) 5'CTCCATCAAAGGCT 3 '(MGB-NFQ) 야생형 검출용 프로브Wild type detection probe 44 RNF213(G) probeRNF213 (G) probe (FAM)5'CTCCATCAGAGGC 3'(MGB-NFQ)(FAM) 5 'CTCCATCAGAGGC 3' (MGB-NFQ)

실시예2. 실시간 중합효소연쇄반응에 의한 RNF213 유전자 돌연변이의 검출Example 2. Detection of mutation of RNF213 gene by real-time polymerase chain reaction

검체로부터 채취한 혈액 샘플로부터 QIAamp DNA Mini Kit(Qiagen, Germany)를 사용하여 게놈(genomic) DNA를 추출하였다. 실시간 PCR 반응에는 실시예 1에서 제조한 프라이머 쌍 및 프로브 쌍을 사용하였다. 표 2는 실시간 PCR 반응에 사용한 마스터 믹스처(master mixture)를 나타낸 것이다. 구체적으로, 상기 추출한 DNA 2 ㎕, 2x PCR reaction mixture(BioSewoom, Seoul, Korea) 12.5 ㎕, 프라이머(5 nM), 야생형 프로브(3nM)와 돌연변이형 프로브(3nM)를 포함하고, 핵산분해효소(nuclease)가 없는 증류수로 총 부피 25 ㎕로 맞춘 반응액에서 실시간 PCR 반응을 실시하였다. 표 3은 실시간 PCR 반응 조건을 나타낸 것이다. 구체적으로, PCR 반응은 50℃에서 2분. 95℃에서 10분; 95℃에서 15초, 60℃ 40초의 40 사이클의 조건으로 CFX96 실시간 PCR 장비(Bio-Rad)에서 수행하였다. 각 사이클마다 VIC와 FAM에 의한 형광을 측정하였다.Genomic DNA was extracted from the blood samples taken from the samples using QIAamp DNA Mini Kit (Qiagen, Germany). For the real-time PCR reaction, primer pairs and probe pairs prepared in Example 1 were used. Table 2 shows the master mixture used in the real-time PCR reaction. Specifically, 2 μl of the extracted DNA, 12.5 μl of a 2 × PCR reaction mixture (BioSewoom, Seoul, Korea), 5 nM of a primer, 3 nM of a wild type probe and 3 nM of a mutant probe, ) Without distilled water and a total volume of 25 μl. Table 3 shows real-time PCR reaction conditions. Specifically, the PCR reaction was carried out at 50 캜 for 2 minutes. 95 ° C for 10 minutes; Real-time PCR equipment (Bio-Rad) under conditions of 40 cycles of 95 ° C for 15 seconds and 60 ° C for 40 seconds. Fluorescence by VIC and FAM was measured for each cycle.

성분ingredient 용량(㎕)Capacity (μl) 2x PCR reaction mixture2x PCR reaction mixture 12.512.5 프라이머 및 프로브 mixturePrimer and probe mixture 33 증류수Distilled water 7.57.5 주형 DNATemplate DNA 22 총 부피Total volume 2525

온도Temperature 시간time 사이클cycle 데이터 수집Data collection 50 ℃50 2분2 minutes 1 사이클1 cycle 95 ℃95 10분10 minutes 1 사이클1 cycle 95 ℃95 ℃ 15초15 seconds 40 사이클40 cycles 60 ℃60 ° C 40초40 seconds 형광 검출 (VIC, FAM)Fluorescence detection (VIC, FAM)

실시간 PCR의 대조군은 표 1에 기재된 프라이머 조합을 이용한 중합효소연쇄반응과 서열결정에 의해 야생형 및 돌연변이형 유전자를 준비하여 이용하였다. 즉, 표 1에 의해 프라이머의 조합을 이용한 중합효소연쇄반응에 의해 수득된 산물을 플라스미드(plasmid) 벡터에 클로닝하고, 이를 대장균에 형질전환시켜 야생형 유전자를 대량으로 준비하고, 서열분석에 의해 염기서열을 확인하고, 야생형 유전자에 부위-특이적 돌연변이 유발 키트를 이용하여 돌연변이 유전자를 준비하고, 서열결정에 의해 확인한 후 이용하였다. 표 4는 실시간 중합효소연쇄반응을 이용하여 RNF213 유전자의 c.14429G>A 돌연변이 부위의 유전자형을 결정하기 위한 키트의 구성요소를 나타낸 것이다.As a control group of real-time PCR, wild type and mutant type genes were prepared and used by polymerase chain reaction and sequencing using the primer combination shown in Table 1. That is, the product obtained by polymerase chain reaction using a combination of primers according to Table 1 was cloned into a plasmid vector, and the resulting product was transformed into Escherichia coli to prepare a large number of wild-type genes. By sequencing, , And a mutant gene was prepared using a site-specific mutagenesis kit for the wild-type gene and confirmed by sequencing. Table 4 shows the components of the kit for determining the genotype of the c.14429G > A mutation site of the RNF213 gene using real-time PCR.

키트 구성요소Kit Components 2x PCR reaction mixture2x PCR reaction mixture 프라이머 및 프로브mixturePrimer and probe mixture 양성 대조군 1 (야생형)Positive control 1 (wild type) 양성 대조군 2 (돌연변이형)Positive control 2 (mutant) 양성 대조군 3 (헤테로형)Positive control group 3 (heterozygous) 증류수Distilled water

FAM 염료에 양성을 나타내는 샘플은 야생형 유전자를 가진 샘플이고, VIC 염료에 양성을 나타내는 샘플은 돌연변이 유전자를 가진 샘플로 진단하였다. VIC와 FAM에 모두 양성을 나타내는 샘플은 야생형과 돌연변이 유전자를 모두 갖는 이형접합 돌연변이(hetero)로 진단하였다. The sample showing positive for the FAM dye was a sample with a wild-type gene and the sample showing positive for the VIC dye was diagnosed as a sample having a mutant gene. Samples showing positive for both VIC and FAM were diagnosed as heterozygous mutations (hetero) with both wild type and mutant genes.

도 2는 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 쌍 및 프로브 쌍을 이용하여 야생형 대조군에 대한 실시간 중합효소연쇄반응을 수행한 결과이다.FIG. 2 shows results of real-time PCR for the wild-type control using primer pair and probe pair for detecting c.14429G> A mutation of RNF213 gene.

도 3은 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 쌍 및 프로브 쌍을 이용하여 돌연변이형 대조군에 대한 실시간 중합효소연쇄반응을 수행한 결과이다.FIG. 3 shows results of real-time PCR for the mutant control group using primer pairs and probe pairs for detecting c.14429G> A mutation of RNF213 gene.

도 4는 RNF213 유전자의 c.14429G>A 돌연변이 검출용 프라이머 쌍 및 프로브 쌍을 이용하여 헤테로형 대조군에 대한 실시간 중합효소연쇄반응을 수행한 결과이다.FIG. 4 shows the result of real-time PCR for the heterozygous control group using primer pair and probe pair for detecting c.14429G> A mutation of RNF213 gene.

도 2 내지 4에 나타낸 바와 같이, 표 1의 프라이머 쌍 및 프로브 쌍을 이용하여, RNF213 야생형, RNF213 돌연변이 동형접합성, 및 RNF213 돌연변이 이형접합성을 명확히 구별할 수 있음을 확인할 수 있었다.As shown in FIGS. 2 to 4, it was confirmed that RNF213 wild type, RNF213 mutant homozygosity, and RNF213 mutant heterozygosity can be clearly distinguished by using the primer pair and the probe pair shown in Table 1.

실시예 3. 임상검체의 유전자형 분석Example 3. Analysis of genotypes of clinical specimens

실시예 1에서 제작된 RNF213 유전자 돌연변이 검출용 프라이머 및 프로브를 사용하여 실제 임상검체를 대상으로 유전자 검사를 실시하였다.Genetic tests were performed on actual clinical specimens using primers and probes for detecting RNF213 gene mutation prepared in Example 1.

먼저 모야모야병과 관련된 증상이 없으나 RNF213 유전자에 대한 돌연변이의 유무가 확인되지 않은 정상인 105명을 모집하였다. 정상인 105명으로부터 채취한 혈액 샘플로부터 QIAamp DNA Mini Kit(Qiagen, Germany)를 사용하여 게놈(genomic) DNA를 추출하였다. 실시간 PCR 반응에는 실시예 1에서 제조한 프라이머 쌍 및 프로브 쌍을 사용하였다. 표 5는 실시간 PCR 반응에 사용한 마스터 믹스처(master mixture)를 나타낸 것이다. 구체적으로, 상기 추출한 DNA 5 ㎕, 2x PCR reaction mixture(BioSewoom, Seoul, Korea) 12.5 ㎕, 프라이머(5 nM), 야생형 프로브(3nM)와 돌연변이형 프로브(3nM)를 포함하고, 핵산분해효소(nuclease)가 없는 증류수로 총 부피 25 ㎕로 맞춘 반응액에서 실시간 PCR 반응을 실시하였다. 실시간 PCR 반응 조건은 실시예 2와 동일하게 하였다. 각 사이클마다 VIC와 FAM에 의한 형광을 측정하였다.We first recruited 105 healthy controls with no symptoms associated with moyamoya disease but no mutations in the RNF213 gene. Genomic DNA was extracted from blood samples collected from 105 normal subjects using QIAamp DNA Mini Kit (Qiagen, Germany). For the real-time PCR reaction, primer pairs and probe pairs prepared in Example 1 were used. Table 5 shows the master mixture used in the real-time PCR reaction. Specifically, 5 μl of the extracted DNA, 12.5 μl of a 2 × PCR reaction mixture (BioSewoom, Seoul, Korea), 5 nM of a primer, 3 nM of a wild type probe and 3 nM of a mutant probe, ) Without distilled water and a total volume of 25 μl. The real-time PCR reaction conditions were the same as in Example 2. Fluorescence by VIC and FAM was measured for each cycle.

성분ingredient 용량(㎕)Capacity (μl) 2x PCR reaction mixture2x PCR reaction mixture 12.512.5 프라이머 및 프로브 mixturePrimer and probe mixture 33 증류수Distilled water 4.54.5 주형 DNATemplate DNA 55 총 부피Total volume 2525

한편, 상기 실시간 PCR 결과가 정확한지 검증하기 위하여, 동일한 105명의 정상인에 대하여 염기서열분석검사를 실시하였다.On the other hand, in order to verify whether the real-time PCR result was correct, 105 normal individuals were subjected to sequencing analysis.

구체적으로, 정상인 105명으로부터 채취한 혈액샘플로부터 DNA를 추출하였다. DNA 추출 시에는 QIAamp DNA Mini Kit(Qiagen, Germany)를 사용하였고 키트의 사용설명서에 따라 DNA를 추출하였다. 추출한 DNA 2 ㎕, 2x PCR mixture(BioSewoom, Seoul, Korea) 12.5 ㎕, 하기 표 6의 RNF213-CF 및 -CR 프라이머(10 nM)를 포함하고, 핵산분해효소(nuclease)가 없는 증류수로 총 부피 25 ㎕로 맞춘 반응액에서 PCR 반응을 실시하였다. PCR 반응은 95℃에서 10분; 95℃에서 30초, 60℃ 30초, 72℃에서 30초의 45 사이클; 72℃에서 5분의 조건으로 AB 2720 PCR 장비(Applied Biosystems)에서 수행하였다. 반응이 끝난 후, PCR 산물은 1.5% 아가로즈 겔 상에서 전기영동을 실시하였으며, UV 분광광도계(Thermo Scientific, USA)에서 PCR 산물을 확인하였다. 이후, 증폭된 PCR 산물에 엑소뉴클레아제 I(20 U/㎕, NEB, UK) 0.2 ㎕, Shrimp alkaline phosphatase(1 U/㎕,NEB, UK) 0.8ul, 10X Exo 버퍼(NEB, UK) 그리고 핵산분해효소(nuclease)가 없는 증류수 4.25 ㎕를 첨가 후, 37℃에서 30분, 85℃ 15분 처리하여 정제하였다. Specifically, DNA was extracted from a blood sample collected from 105 normal persons. For DNA extraction, QIAamp DNA Mini Kit (Qiagen, Germany) was used and DNA was extracted according to the instruction manual of the kit. 12.5 ㎕ of the extracted DNA, 2 PCR of the 2x PCR mixture (BioSewoom, Seoul, Korea), and RNF213-CF and -CR primer (10 nM) of the following Table 6 were mixed with distilled water having no nuclease Lt; / RTI > in the reaction solution. The PCR reaction was carried out at 95 캜 for 10 minutes; 45 cycles of 30 sec at 95 캜, 30 sec at 60 캜, and 30 sec at 72 캜; Gt; 72 C < / RTI > for 5 minutes in an AB 2720 PCR instrument (Applied Biosystems). After the reaction, the PCR products were electrophoresed on 1.5% agarose gel and PCR products were confirmed by UV spectrophotometer (Thermo Scientific, USA). Then, 0.2 μl of exonuclease I (20 U / μl, NEB, UK), 0.8 μl of Shrimp alkaline phosphatase (1 U / μl, NEB, UK), 10 × Exo buffer (NEB, UK) After addition of 4.25 μl of distilled water without nuclease, the mixture was treated at 37 ° C for 30 minutes and at 85 ° C for 15 minutes.

정제된 PCR 산물에 40 ㎕의 핵산분해효소(nuclease)가 없는 증류수를 첨가한 반응물 1~2.5 ㎕, 하기 표 6의 RNF213-CR 염기서열분석 프라이머 2 nM, 5X 염기서열분석 버퍼(Applied Biosystems, USA) 3.2 ㎕, BigDye Terminator v3.1 Cycle Sequencing RR-100(Applied Biosystems, USA) 0.8 ㎕를 포함하고 핵산분해효소(nuclease)가 없는 증류수로 총 부피 10 ㎕로 맞추어 염기서열분석 반응을 실시하였다. 염기서열분석 반응은 96℃에서 1분; 96℃에서 10초, 50℃ 5초, 60℃에서 4분의 25 사이클의 조건으로 AB 2720 PCR 장비(Applied Biosystems)에서 시행하였다. 반응이 끝난 후, Magbesil®GREEN(Promega, USA)의 사용법에 따라 정제를 진행한 다음, 진공 농축기(vacuum concentrator)를 이용하여 정제된 DNA를 완전히 건조시킨 후, 용출 버퍼(Elution Buffer) 30 ㎕를 첨가하여 완전히 용해시켰다. 이 중 15 ㎕를 염기서열분석 플레이트에 분주하여 3730xl DNA 분석기(Applied biosystems, USA)로 반응을 진행하고, Sequencing Analysis 5.1.1 소프트웨어(Applied biosystems, USA)를 사용하여 염기서열 분석을 실시하였다. 분석된 염기서열 정보에서 RNF213 p.R4810K (c.14429G>A) 변이 여부를 확인하였다.1 to 2.5 μl of a reaction mixture containing 40 μl of nuclease-free distilled water was added to the purified PCR product, 2 nM of RNF213-CR nucleotide sequencing analysis primer and 5 × sequencing analysis buffer (Applied Biosystems, USA ) 3.2 ㎕, BigDye Terminator v3.1 Cycle Sequencing Sequencing analysis was performed by adding 0.8 ㎕ of RR-100 (Applied Biosystems, USA) and distilled water with no nuclease in total volume of 10 ㎕. Sequencing reactions were performed at 96 ° C for 1 min; (Applied Biosystems) with 25 cycles of 96 ° C for 10 seconds, 50 ° C for 5 seconds, and 60 ° C for 4 minutes. After the reaction was completed, purification was carried out according to the method of using Magbesil®GREEN (Promega, USA), and the purified DNA was completely dried using a vacuum concentrator. Then, 30 μl of elution buffer And completely dissolved. 15 μl of the resulting solution was added to a nucleotide sequencing plate and reacted with a 3730 × 1 DNA analyzer (Applied Biosystems, USA). Sequencing analysis was performed using Sequencing Analysis 5.1.1 software (Applied biosystems, USA). The mutated nucleotide sequence was analyzed to confirm the mutation of RNF213 p.R4810K (c.14429G> A).

서열번호SEQ ID NO: 명칭designation 서열order 증폭산물 크기(bp)Amplification product size (bp) 66 RNF213-CF primerRNF213-CF primer 5' actgggtggtcttcccttct 3' (정방향)5 'actgggtggtcttcccttct 3' (forward) 388 bp388 bp 77 RNF213-CR primerRNF213-CR primer 5' gaaggagtgagccgagtttg 3' (역방향)5 'gaaggagtgagccgagtttg 3' (reverse direction)

도 5는 정상인 105명에 대하여 실시간 PCR과 염기서열분석을 수행하여 결정된 RNF213 c.14429G>A 돌연변이 부위의 유전자형 분석 결과이다. FIG. 5 is a result of genotyping analysis of RNF213 c.14429G > A mutation site determined by real-time PCR and nucleotide sequence analysis for 105 healthy individuals.

도 6은 정상인 105명에 대하여 실시간 PCR을 수행하여 4건의 이형접합성(heterozygosity)을 확인한 결과이다.FIG. 6 shows the result of confirming four heterozygosity by performing real-time PCR on 105 normal subjects.

도 7은 정상인 105명 중 4명의 이형접합성 검체 즉, #16, #19, #23 및 #43에 대한 실시간 PCR 및 염기서열분석 결과이다.FIG. 7 shows real-time PCR and nucleotide sequence analysis results for four heterozygous samples of # 105, that is, # 16, # 19, # 23 and # 43.

도 5 내지 7에 나타낸 바와 같이, 실시간 PCR에 의해 확인된 유전자형과 염기서열분석에 의한 유전자형의 결과가 일치하는 것을 확인하였다. 즉, RNF213 돌연변이 검출용 프라이머 및 프로브를 포함하는 진단용 조성물을 사용하여 돌연변이 보인자들의 각 돌연변이를 100% 정확하게 검출할 수 있었다. As shown in FIGS. 5 to 7, it was confirmed that the genotype confirmed by real-time PCR coincided with the genotype obtained by base sequence analysis. That is, using the diagnostic composition comprising the primer and the probe for RNF213 mutation detection, each mutation of the mutant carriers could be detected with 100% accuracy.

비교예Comparative Example 1.  One. 프라이머primer  And 프로브의Of the probe 서열에 따른  According to sequence RNF213RNF213 돌연변이 검출 특이성의 확인 Identification of mutation detection specificity

RNF213 c.14429G>A 돌연변이 부위를 검출할 수 있는 다양한 종류의 프라이머 및 프로브를 이용하여 실시간 중합효소연쇄반응을 수행한 후, 검출 특이성을 확인하는 실험을 하였다.RNF213 c.14429G> Real-time PCR was performed using various primers and probes capable of detecting the A mutation site, and then experiments were carried out to confirm detection specificity.

구체적으로, 하기 표 7에 기재된 정방향 프라이머, 역방향 프라이머 및 돌연변이형 검출용 프로브를 다양한 조합으로 사용하여 실시예 2와 동일한 방법으로 실시간 중합효소연쇄반응을 수행하였다. 실험에 사용한 정방향 프라이머, 역방향 프라이머 및 돌연변이형 검출용 프로브의 조합은 다음과 같다:Specifically, real-time PCR was carried out in the same manner as in Example 2, using various combinations of the forward primer, reverse primer and mutant type detection probe described in Table 7 below. The combinations of the forward primer, reverse primer and mutation detection probe used in the experiment are as follows:

(1) F1 primer, R1 primer, 및 ZEN probe(1) F1 primer, R1 primer, and ZEN probe

(2) F2 primer, R1 primer, 및 ZEN probe (2) F2 primer, R1 primer, and ZEN probe

(3) F3 primer, R1 primer, 및 ZEN probe(3) F3 primer, R1 primer, and ZEN probe

(4) F4 primer, R1 primer, 및 ZEN probe(4) F4 primer, R1 primer, and ZEN probe

(5) F5 primer, R1 primer, 및 ZEN probe(5) F5 primer, R1 primer, and ZEN probe

(6) F6 primer, R1 primer, 및 ZEN probe(6) F6 primer, R1 primer, and ZEN probe

유형type 서열번호SEQ ID NO: 명칭designation 서열order 정방향 프라이머Forward primer 88 F1 primerF1 primer 5'-AGCAAGTTGAATACAGCTCCATTAA-3'5'-AGCAAGTTGAATACAGCTCCATTAA-3 ' 정방향 프라이머Forward primer 99 F2 primerF2 primer 5'-AGCAAGTTGAATACAGCTCCATTAAA-3'5'-AGCAAGTTGAATACAGCTCCATTAAA-3 ' 정방향 프라이머Forward primer 1010 F3 primerF3 primer 5'-GCAAGTTGAATACAGCTCCATGAA-3'5'-GCAAGTTGAATACAGCTCCATGAA-3 ' 정방향 프라이머Forward primer 1111 F4 primerF4 primer 5'-CAAGTTGAATACAGCTCCAACAA-3'5'-CAAGTTGAATACAGCTCCAACAA-3 ' 정방향 프라이머Forward primer 1212 F5 primerF5 primer 5'-CAAGTTGAATACAGCTCCACCAA-3'5'-CAAGTTGAATACAGCTCCACCAA-3 ' 정방향 프라이머Forward primer 1313 F6 primerF6 primer 5'-CAAGTTGAATACAGCTCCAGCAA-3'5'-CAAGTTGAATACAGCTCCAGCAA-3 ' 역방향 프라이머Reverse primer 1414 R1 primerR1 primer 5'-CCCTATGCAGTGATCCTTTCG-3'5'-CCCTATGCAGTGATCCTTTCG-3 ' 돌연변이형 검출용 프로브The mutation detection probe 1515 ZEN probeZEN probe 5'-/6-FAM/ACCAGGACT/ZEN/GTCCCGCATTTGGC/IABkFQ/-3'5 '- / 6-FAM / ACCAGGACT / ZEN / GTCCCGCATTTGGC / IABkFQ / -3'

도 8은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F1 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다. 도 8에 나타낸 바와 같이, 야생형에서도 증폭 신호가 관찰되었고, 주형을 넣지 않은 NTC(Non-template control)에 대해서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.Fig. 8 shows results of real-time PCR using F1 primer, R1 primer and ZEN probe to detect RNF213 c.14429G > A mutation. As shown in Fig. 8, the amplified signal was observed in the wild type as well as the amplified signal was observed in the NTC (Non-template control) not containing the template. Therefore, the combination of the primer and the probe showed detection specificity for the mutation by nonspecific amplification Respectively.

도 9 및 10은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F2 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다. 도 9 및 10에 나타낸 바와 같이, 야생형에서도 증폭 신호가 관찰되었고, 염기서열분석검사로 RNF213 c.14429G>A 돌연변이 음성으로 확인된 음성검체에 대해서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.FIGS. 9 and 10 show results of real-time PCR using F2 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G> A mutation. As shown in FIGS. 9 and 10, the amplified signal was observed in the wild type as well, and the amplified signal was also observed in the negative specimen identified as RNF213 c.14429G > A mutant negative by the sequencing analysis. Therefore, the primer and the probe combination were non- It was judged that amplification resulted in low detection specificity for the mutation.

도 11은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F3 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다. 도 11에 나타낸 바와 같이, 야생형에서도 증폭 신호가 관찰되었고, 주형을 넣지 않은 NTC에 대해서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.Figure 11 shows the result of real-time PCR using F3 primer, R1 primer and ZEN probe to detect RNF213 c.14429G > A mutation. As shown in Fig. 11, the amplified signal was observed in the wild type as well as the amplified signal was observed in the non-template NTC. Therefore, it was judged that the combination of the primer and the probe had a low detection specificity for the mutation by nonspecific amplification.

도 12는 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F4 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다. 도 12에 나타낸 바와 같이, 야생형에서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.FIG. 12 shows results of real-time PCR using F4 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G> A mutation. As shown in Fig. 12, since the amplified signal was observed also in the wild type, it was judged that the combination of the primer and the probe had a low detection specificity for the mutation by nonspecific amplification.

도 13은 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F5 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다. 도 13에 나타낸 바와 같이, 야생형에서도 증폭 신호가 관찰되었고, 주형을 넣지 않은 NTC에 대해서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.Fig. 13 shows results of real-time PCR using F5 primer, R1 primer and ZEN probe for detecting RNF213 c.14429G > A mutation. As shown in Fig. 13, the amplified signal was observed in the wild type as well as the amplified signal was observed in the non-template NTC. Therefore, the combination of the primer and the probe was judged to have low detection specificity for the mutation by nonspecific amplification.

도 14 및 15는 RNF213 c.14429G>A 돌연변이를 검출하기 위한 F6 primer, R1 프라이머 및 ZEN probe를 사용하여 실시간 중합효소연쇄반응을 수행한 결과이다. 도 14 및 15에 나타낸 바와 같이, 야생형에서도 증폭 신호가 관찰되었고, 염기서열분석검사로 RNF213 c.14429G>A 돌연변이 음성으로 확인된 음성검체에 대해서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.FIGS. 14 and 15 are results of real-time PCR using F6 primer, R1 primer and ZEN probe to detect RNF213 c.14429G> A mutation. As shown in FIGS. 14 and 15, the amplified signal was observed in the wild type as well, and the amplified signal was also observed in the negative specimen identified as RNF213 c.14429G> A mutant negative by the sequencing analysis. Therefore, the primer and the probe combination were non- It was judged that amplification resulted in low detection specificity for the mutation.

상기와 같이 구체적인 서열이 다른 다양한 조합의 프라이머 및 프로브를 사용하였을 때 검출 특이성이 낮은 것과 달리, 실시예 1에서 제조한 프라이머 및 프로브는 검출 특이성이 매우 높으므로 RNF213 c.14429G>A 돌연변이 부위의 유전자형을 분석하기에 가장 적합하다는 것을 확인할 수 있었다.Unlike the case of using various combinations of primers and probes having different sequences as described above, the primers and probes prepared in Example 1 have a very high detection specificity, so that the detection specificity is low. Therefore, the genotype of the RNF213 c.14429G > A mutation site Which is the most suitable for analyzing.

비교예Comparative Example 2.  2. 프라이머primer  And 프로브의Of the probe 서열에 따른  According to sequence RNF213RNF213 야생형 또는  Wild type or 돌연변이형Mutant type 검출 특이성의 확인 Identification of detection specificity

RNF213 c.14429G>A 돌연변이 부위의 유전자형을 분석할 수 있는 다양한 종류의 프라이머 및 프로브를 이용하여 음성 검체에서 실시간 중합효소연쇄반응을 수행한 후, 각각의 야생형 검출용 프로브 또는 돌연변이형 검출용 프로브에 의해 비특이적 증폭이 발생하는지 확인하는 실험을 하였다.RNF213 c.14429G> Real-time PCR was performed on the negative samples using various types of primers and probes capable of analyzing the genotype of the A mutant site, and then each of the wild type detection probes or the mutant type detection probes To confirm whether nonspecific amplification occurs.

구체적으로, 하기 표 8에 기재된 정방향 프라이머, 역방향 프라이머, 돌연변이형 검출용 프로브 및 야생형 검출용 프로브를 다양한 조합으로 사용하여 염기서열분석검사로 RNF213 c.14429G>A 돌연변이 음성으로 확인된 검체 DNA에 대해 실시예 2와 동일한 방법으로 실시간 중합효소연쇄반응을 수행하였다.Specifically, with respect to the sample DNA identified as RNF213 c.14429G > A mutant negative by the base sequence analysis test using various combinations of the forward primer, reverse primer, mutant type detection probe and wild type detection probe described in Table 8 below Real-time polymerase chain reaction was performed in the same manner as in Example 2.

유형type 서열번호SEQ ID NO: 명칭designation 서열order 정방향 프라이머Forward primer 1616 RNF213_Zen F1 primerRNF213_Zen F1 primer 5’CAGTTCCAGAACGTCCAGCAA 3’5 'CAGTTCCAGAACGTCCAGCAA 3' 정방향 프라이머Forward primer 1717 RNF213_Zen F2 primerRNF213_Zen F2 primer 5’ GTTCCAGAACGTCCAGCAA 3’5 'GTTCCAGAACGTCCAGCAA 3' 역방향 프라이머Reverse primer 1818 RNF213_Zen R1 primerRNF213_Zen R1 primer 5’TTTCGAACCGCCAAATGC 3’5'TTTCGAACCGCCAAATGC 3 ' 돌연변이형 검출용 프로브The mutation detection probe 1919 RNF213(ZEN-A1) probeRNF213 (ZEN-A1) probe (FAM) 5’AATACAGCTCCATCAAAGGCTTCCTCA 3’ (IABkFQ)(FAM) 5'AATACAGCTCCATCAAAGGCTTCCTCA 3 '(IABkFQ) 돌연변이형 검출용 프로브The mutation detection probe 2020 RNF213(ZEN-A2) probeRNF213 (ZEN-A2) probe (FAM) 5’CAGCTCCATCAAAGGCTTCCTCA 3’ (IABkFQ)(FAM) 5'CAGCTCCATCAAAGGCTTCCTCA 3 '(IABkFQ) 야생형 검출용 프로브Wild type detection probe 2121 RNF213(ZEN-G1) probeRNF213 (ZEN-G1) probe (HEX) 5’TTGAATACAGCTCCATCAGAGGCTTCC 3’ (IABkFQ)(HEX) 5 'TTGAATACAGCTCCATCAGAGGCTTCC 3' (IABkFQ) 야생형 검출용 프로브Wild type detection probe 2222 RNF213(ZEN-G2) probeRNF213 (ZEN-G2) probe (HEX) 5’CAGCTCCATCAGAGGCTTCC 3’ (IABkFQ)(HEX) 5 'CAGCTCCATCAGAGGCTTCC 3' (IABkFQ)

도 16은 구체적인 서열이 다른 다양한 조합의 프라이머 및 프로브를 사용하여 음성 검체에 대해 실시간 중합효소연쇄반응을 수행한 결과이다. 도 16에 나타낸 바와 같이, 음성검체에 대해서도 증폭 신호가 관찰되었으므로, 상기 프라이머 및 프로브 조합은 비특이적 증폭에 의해 야생형 또는 돌연변이에 대한 검출 특이성이 낮은 것으로 판단되었다.16 is a result of performing a real-time PCR on negative samples using various combinations of primers and probes having different sequences. As shown in Fig. 16, amplification signals were also observed for the negative specimens. Therefore, it was judged that the combination of the primers and probes had a low detection specificity for wild type or mutation by nonspecific amplification.

이와 달리, 실시예 1에서 제조한 프라이머 및 프로브는 검출 특이성이 매우 높으므로 RNF213 c.14429G>A 돌연변이 부위의 유전자형을 분석하기에 가장 적합하다는 것을 확인할 수 있었다.In contrast, the primers and probes prepared in Example 1 were found to be most suitable for analyzing the genotype of RNF213 c.14429G > A mutant site because the detection specificity was very high.

<110> Samsung Life Public Welfare Foundation BIOSEWOOM, INC. <120> Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof <130> PN115412KR <160> 22 <170> KoPatentIn 3.0 <210> 1 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> RNF-MGB F1 primer <400> 1 agaacgtcca gcaagttgaa taca 24 <210> 2 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> RNF-MGB R1 primer <400> 2 tttcgaaccg ccaaatgc 18 <210> 3 <211> 14 <212> DNA <213> Artificial Sequence <220> <223> RNF213(A) probe <400> 3 ctccatcaaa ggct 14 <210> 4 <211> 13 <212> DNA <213> Artificial Sequence <220> <223> RNF213(G) probe <400> 4 ctccatcaga ggc 13 <210> 5 <211> 21062 <212> DNA <213> Homo sapiens <400> 5 ggggcgacag cgcgcggcag gcggcgagct cgggggccgc agaaaatgaa actgaagccg 60 tggtcacgtg acaggacatg tagtatatag caggctgcca gcgactcctg ctcttgcttc 120 tggatctgca gggcagtccc agcaggaccc atggagtgtc cttcgtgcca gcatgtctcc 180 aaggaggaaa cccccaagtt ctgcagccag tgcggagaga ggctgcctcc tgcagccccc 240 atagcagatt ctgagaacaa taactccaca atggcgtcgg cctcggaggg tgaaatggag 300 tgtgggcagg agctgaagga ggaagggggc ccgtgcttgt tcccgggctc agacagttgg 360 caagaaaacc ccgaggagcc ctgttccaaa gcctcctgga ccgtccaaga aagcaaaaag 420 aagaaaagga agaagaaaaa gaaggggaac aagtccgctt cctcagagct ggcttccttg 480 cccctttctc ctgccagccc ctgtcacctg actttgcttt caaacccgtg gcctcaggac 540 acagccctgc cccacagcca agcccagcag agtggcccca ctggccagcc gagccagccc 600 ccaggcacag ccaccacgcc actggagggt gacggcctct ccgcgcccac cgaggttggc 660 gacagccccc tgcaggccca ggctttggga gaggcaggag tggccacagg aagtgaggct 720 cagagcagcc cgcaattcca ggaccacacg gaaggggagg accaggacgc ttccatcccc 780 tctgggggca gaggcctgtc ccaggagggg accggtcccc ccacctctgc tggtgaaggc 840 cattctagga ctgaagatgc tgcccaggag ctcctgttgc ctgagtcaaa aggaggcagc 900 tctgagcccg ggacagaact gcagaccacc gagcaacagg caggggcctc agcctctatg 960 gcagttgatg ctgtagctga gccagccaat gcagttaaag gggccgggaa ggaaatgaaa 1020 gagaagaccc agagaatgaa acagccacca gcaaccactc ctcctttcaa aacacactgc 1080 caggaagctg agaccaagac caaggacgag atggctgctg ctgaagaaaa agtcggtaag 1140 aatgaacaag gggagcctga agacctcaag aagccagagg ggaagaacag aagtgcagct 1200 gctgtgaaaa acgagaagga gcaaaaaaac caggaagcag atgtccagga agtgaaggca 1260 agcacgctga gcccgggtgg aggagtcacc gtgttcttcc acgccatcat ctctcttcat 1320 ttcccattca atcctgacct ccataaagtc ttcatcagag gaggagaaga atttggggag 1380 tcaaaatggg acagcaatat ctgtgagctg cactacacca gagacttggg tcatgaccgc 1440 gttcttgttg aaggcattgt ctgcatttcc aagaagcacc tagataaata cattccttac 1500 aagtacgtca tttataatgg ggaatctttt gagtatgagt tcatttacaa gcaccagcag 1560 aagaagggcg agtacgtcaa ccgctgtctg ttcataaaat cttcacttct gggctcagga 1620 gactggcatc agtactatga catagtttat atgaagcctc atgggagact ccagaaagtc 1680 atgaaccaca tcacagacgg gccgaggaag gacctggtga aggggaagca gattgccgct 1740 gcgctcatgc tggacagcac cttcagcatc ctgcagacct gggacaccat caacctgaac 1800 agcttcttca cccagttcga gcagttttgc tttgtcctgc aacagcctat gatttatgaa 1860 ggacaggcac agctgtggac cgatttgcag tacagggaga aagaggtgaa gagatacctg 1920 tggcaacatc tgaaaaaaca cgtggtacca ttgccggacg gaaaaagcac ggactttttg 1980 cctgtggact gcccagtgag gagtaaactg aaaacaggcc tgattgtcct ttttgtagtg 2040 gaaaaaattg agcttttatt agaaggcagc ctggactggt tgtgtcacct cctaacctca 2100 gatgccagct caccagatga gtttcaccgt gacctaagcc acatccttgg gatacctcag 2160 agctggcggc tgtacctggt gaacctgtgc caaagatgca tggacacaag gacgtacacc 2220 tggctgggcg ccctgcctgt cctgcactgc tgtatggagc tggccccgcg gcacaaggat 2280 gcctggagac agcctgagga cacctgggcc gctctggagg gactctcctt ctcaccgttc 2340 cgggaacaaa tgctagatac gagttcccta cttcagttta tgagagagaa gcagcatttg 2400 ctgagcatag acgagcctct cttccggtcc tggtttagtc tgctacctct gagtcacctg 2460 gttatgtata tggaaaactt cattgagcac ctgggtcgtt ttcctgctca tatcctggac 2520 tgtctttcag ggatttacta ccggcttccg ggacttgagc aagtcttgaa tacgcaggat 2580 gttcaggatg ttcagaacgt tcagaacatt ttagaaatgc tgttgcgact cctggacact 2640 taccgggaca agattcccga ggaggccttg tcaccatcct acctgactgt gtgtctgaaa 2700 ctgcatgaag ccatctgcag cagcacaaag ctacttaagt tttacgagct gccagcctta 2760 tctgccgaga ttgtctgcag aatgattaga cttctatctc tggtggattc tgcaggacag 2820 agagatgaaa ctggaaataa ttcagtccaa acagtcttcc aagggaccct tgctgctacg 2880 aaaaggtggc tccgagaagt ttttacaaag aacatgctca catcttcagg tgcctcattc 2940 acatacgtca aggaaattga ggtctggagg cggctggtgg aaatccaatt ccccgcggag 3000 catggctgga aggagtcgtt gctgggagac atggaatgga ggctcacaaa ggaggaaccc 3060 ctctcccaga tcactgccta ctgcaatagt tgctgggaca ccaaaggctt agaggacagt 3120 gtggccaaga ccttcgagaa atgcatcatt gaagccgtga gctcagcctg ccagtctcag 3180 accagtatcc ttcaggggtt ctcttactct gatttgcgga aatttggcat cgtcttgtct 3240 gctgtgatca ctaagtcctg gcctaggacc gcggacaact tcgatgacat tttaaagcat 3300 ctgctcacgt tggcagatgt caagcacgtc ttcagattgt gtggaaccga cgagaaaata 3360 ctagcaaatg tcacagagga tgccaagagg ctgatagctg ttgccgactc tgtgttgacg 3420 aaagttgttg gtgacctcct aagtggcacg attttagttg gacaactgga gctgattata 3480 aagcacaaga atcagtttct tgacatctgg caactgaggg aaaaaagtct ttcaccccag 3540 gatgaacaat gtgctgtgga ggaagcactg gattggagaa gggaggaact gttacttcta 3600 aagaaagaga aaagatgtgt tgatagtctc ctgaagatgt gtgggaacgt gaaacatctg 3660 atacaagtgg actttggagt gcttgcagta agacactcac aagacctcag cagtaaaaga 3720 ttaaatgaca ccgtgacagt gagactgtcc acctcctcga actcgcagag ggcaacgcat 3780 taccacctga gctcccaggt ccaagaaatg gctgggaaga tagacttgct cagagacagc 3840 cacatcttcc agctcttctg gcgggaagcc gcagagccgc tgagtgagcc taaggaggac 3900 caggaagccg cagagttgct gagtgagccc gaagaagaat cagaaaggca catccttgag 3960 cttgaagagg tgtatgacta tttgtatcag ccttcttaca gaaagttcat taagttgcac 4020 caggatctaa agtcaggaga ggtcaccctt gcagagattg atgtcatctt caaggacttt 4080 gtgaataaat acacggacct ggattcagaa cttaagatca tgtgcaccgt ggaccaccag 4140 gaccaaagag attggatcaa ggaccgagtc gaacagatca aggaatacca tcacctgcac 4200 caggctgtcc acgcagccaa ggtcatcttg caggtcaaag agagcctggg actgaacggt 4260 gacttcagtg ttctcaacac tttactaaat tttactgata acttcgacga ctttcgccgt 4320 gaaacactgg accagatcaa ccaggagctc atccaggcca aaaagctgct ccaggacatc 4380 agcgaggccc ggtgcaaggg gctgcaggct ctgtccctga gaaaggagtt catctgctgg 4440 gtccgggagg ctcttggagg catcaatgag ctgaaggtgt ttgtggacct ggcctccatc 4500 tcagcggggg agaatgacat tgatgtggac cgggtggcct gcttccatga cgctgtgcag 4560 ggctacgcat ccctgctatt taagctggac cccagcgtgg acttcagtgc attcatgaag 4620 catctgaaaa agctgtggaa ggctctggat aaggaccagt acctgcccag gaaactgtgt 4680 gactccgcca ggaacttgga atggctgaag actgtgaatg agagtcatgg gtctgtggaa 4740 cgctcatccc tgaccctggc cacggccatc aaccaaagag gcatctatgt gatccaggcg 4800 cccaaaggtg gccaaaagat ttccccagac acggttctgc acttgatcct tcctgagagc 4860 cctggcagcc acgaggagtc acgagagtac tctttagagg aggtgaagga gcttttgaac 4920 aagttgatgc tgatgtctgg caagaaggat cgtaacaaca cggaagtgga gaggttttca 4980 gaggtcttct gcagtgtgca gaggctcagc caggccttca tcgacctgca ctctgctggg 5040 aatatgctgt tcaggacgtg gatcgccatg gcctactgct cccccaagca gggtgtgtcc 5100 ctccaaatgg actttggctt ggacctggtg acggagctta aagaaggtgg agatgtcact 5160 gagctgctgg cagccctctg caggcagatg gagcacttcc ttgacagctg gaagagattt 5220 gtgacccaga agcgaatgga gcacttttac ctgaacttct acacggcaga gcagctggtt 5280 tacctgagca ctgagctcag gaagcagccc ccgagtgatg ccgccctaac gatgctatcc 5340 ttcatcaaaa gcaactgcac cctgagggat gtcttaaggg cctctgtggg gtgtgggagt 5400 gaggccgcca ggtaccgcat gaggagagtc atggaagagc tcccgctgat gctcttatca 5460 gagttcagcc tggtggacaa gctgaggatc atcatggagc agtccatgag gtgccttcct 5520 gccttcctgc ccgactgcct cgacctagag acccttggcc actgtctggc tcacctggca 5580 gggatgggtg ggtctcccgt ggagcgttgt ctcccgagag gtctgcaggt cggccagccc 5640 aacctcgtcg tctgtggcca ctccgaggtg ttgccagccg ccctggctgt ctacatgcaa 5700 accccaagcc agcccctgcc cacttacgat gaggtgctgc tctgcacccc ggcaaccacc 5760 tttgaggagg tggcactgtt gctgcgccgc tgcctgaccc tgggctccct ggggcacaag 5820 gtctacagcc tgctgttcgc agatcagctg agctacgagg tggcacgcca agcggaggag 5880 cttttccaca atctgtgcac gcagcagcac cgagaagact accagctcgt catggtctgt 5940 gatggggact gggagcactg ctacctcccc tctgccttca gccagcacaa ggtcttcgtc 6000 accccccagg cacccctcga ggccatccaa gcctacctgg caggtcacta ccgggtcccg 6060 aagcagaccc tgtcggcggc agccgtgttc aatgaccggc tgtgtgttgg gatcgtggcc 6120 tcggagcgag caggtgttgg aaagtctctg tacgtgaaga ggttgcacga caaaatgaag 6180 atgcagttaa acgtgaaaaa tgtgcctctg aaaacaattc gactgatcga ccctcaggtg 6240 gatgagagcc gagtcctggg cgccctgctg cccttcctgg atgcgcagta tcagaaggtc 6300 cccgtgctct ttcacctgga cgtgacctcc tcagtgcaga ctggaatttg ggtgtttctt 6360 ttcaagctcc tcattttaca atacttaatg gatataaatg ggaaaatgtg gcttcggaac 6420 ccctgccatt tgtatatcgt tgaaatcctg gaaaggagga cgtcagtgcc gtcgaggagc 6480 tcttcagcgc tgcgtacacg tgtaccccag ttcagttttc ttgacatctt cccaaaagtc 6540 acctgcaggc ctcccaaaga ggtgatagac atggagctga gtgccctgag gagtgacaca 6600 gagcctggga tggatctgtg ggagttctgc agcgaaactt tccaaagacc ttaccagtat 6660 ttaagacgat tcaatcaaaa ccaagaccta gacacgtttc agtatcaaga aggctctgtc 6720 gaaggcaccc cggaggaatg cctccagcat ttcctgtttc actgcggggt aataaaccca 6780 tcctggtcag agcttcggaa ctttgctcgg ttcctgaatt atcagctcag agattgtgag 6840 gcctctctct tctgcaatcc gagttttatt ggcgacacac tgaggggctt caagaagttc 6900 gtggtgacct tcatgatctt tatggcaaga gattttgcca caccatcact ccacacctct 6960 gaccaaagcc cggggaagca catggtcacc atggatgggg ttagggaaga agatctagcg 7020 cccttctccc tccggaagag gtgggagtcg gagcctcacc catacgtttt cttcaatgac 7080 gaccacacaa ccatgacatt catcggcttc catctgcagc ccaacatcaa cggcagtgtc 7140 gatgccatca gtcacttgac tgggaaggtc atcaagagag acgtcatgac cagggacctg 7200 taccagggcc tgctgctcca gagggtgccc ttcaatgtcg actttgataa actgcccaga 7260 cacaagaaac ttgagaggct ctgcctgacc ttagggatcc cccaggccac cgaccccgac 7320 aaaacgtatg agctcacaac cgacaatatg cttaaaatcc ttgccatcga gatgcggttc 7380 cggtgtggga tcccggttat catcatggga gaaactggct gtgggaaaac caggcttatt 7440 aaattcctta gcgacctgcg gcgtggtggt accaatgctg acaccataaa gctggtcaag 7500 gtgcacggag gaacaactgc agacatgatc tactccagag tcagggaggc tgaaaatgtg 7560 gccttcgcca ataaggacca acatcagttg gacaccatct tgttttttga tgaagccaac 7620 acaacggaag ctataagctg tatcaaagaa gtcctgtgtg atcatatggt ggatggccag 7680 cctctggctg aggactctgg cctgcatatt atagctgcct gcaatccata ccggaagcac 7740 tctgaggaga tgatctgccg tttggagtca gctggtttgg gctacagggt tagtatggag 7800 gagacggccg acaggctggg ctccattcct ctgaggcagc tggtataccg ggtccatgct 7860 ctgcccccga gcctgattcc tctggtgtgg gactttggac aactgagtga cgttgctgaa 7920 aagctctaca tccagcagat tgtccagaga ctggttgagt ccatcagcct agatgaaaac 7980 gggactcgcg tgatcacaga agtcctctgc gcctctcagg gtttcatgag gaaaacagaa 8040 gatgagtgca gctttgtcag cctcagggac gtggagcgct gtgtgaaagt tttcaggtgg 8100 ttccacgagc acagcgcgat gctcttagcg cagctgaatg cctttctctc caagtccagc 8160 gtcagcaaaa atcacaccga gagagatccc gtcctctggt cgttgatgct ggccatcggg 8220 gtgtgttacc atgcctcttt agaaaagaaa gactcatatc ggaaagccat cgccaggttc 8280 tttccgaaac cgtatgacga cagcaggctg cttctggatg aaataacacg ggcacaggat 8340 ctttttctgg acggcgtacc tctgaggaaa accatcgcca agaacttggc cttgaaggag 8400 aacgtcttca tgatggtcgt ctgcatcgag ctgaagattc ccctcttcct ggtggggaag 8460 cccggcagct ccaagtctct cgccaagacc atcgtggcag acgccatgca gggcccggct 8520 gcctactcag atctcttccg cagcctgaag caggtccacc tggtgtcctt ccagtgcagc 8580 ccgcactcca ccccacaggg catcatcagc accttccggc agtgcgcccg ctttcagcag 8640 gggaaggacc tgcagcagta cgtctctgtg gtggtgttag atgaggtggg gctggcggaa 8700 gactcaccca aaatgcccct gaagactctg cacccgctgc tggaagacgg atgcattgaa 8760 gacgatcccg ccccccacaa aaaggtcggc ttcgtgggca tctccaactg ggcccttgac 8820 cctgccaaga tgaaccgggg catttttgtg tcacgtggca gccccaacga gacagagctc 8880 atagagagcg ccaagggcat ctgctcctca gacatcctcg tccaggaccg agtccaaggg 8940 tactttgcgt cctttgccaa agcctacgaa acggtgtgta agcgccagga caaggaattc 9000 ttcgggcttc gtgactacta cagcctcatc aaaatggtct ttgctgcagc aaaggcttca 9060 aatagaaagc cttccccgca agacattgca caggctgtcc ttaggaactt cagtggcaag 9120 gatgacatcc aagctttgga catctttctg gccaatttgc ccgaggccaa gtgctcagag 9180 gaagtcagcc ccatgcagct gatcaaacag aacatctttg ggccttctca gaaggtgccg 9240 ggtggagagc aggaagatgc tgagtcccgc tacttactcg tgctgaccaa aaactacgtg 9300 gcactgcaga tcctgcagca gacattcttc gagggggacc agcagccgga gattattttt 9360 ggttctggtt tccccaagga ccaagagtac acccagctct gcagaaacat caatcgtgtg 9420 aagatctgca tggaaacagg caagatggtg ttgcttctca acctgcagaa cctctacgag 9480 agcctctacg acgcactcaa ccagtactac gtccacctcg gcggccagaa gtacgtggac 9540 ctcggtctgg ggacccaccg cgtcaaatgt cgggttcacc ccaacttccg cctgattgtc 9600 attgaagaga aagacgtcgt gtacaaacac tttcccatcc ccctcattaa ccggctggag 9660 aagcactatc tggatatcaa cacggtgctg gagaaatggc agaagagcat cgtggaggag 9720 ctctgtgcgt gggtggagaa gttcatcaat gtcaaagcac atcatttcca gaagaggcac 9780 aaatacagcc cctctgacgt cttcatcggc taccactcgg acgcctgcgc gtctgtggtg 9840 ctgcaggtca tagagaggca gggtccccgg gccttgacgg aggaacttca ccagaaggtg 9900 tctgaggagg ccaaatcgat cctgctgaac tgcgctacgc ccgatgccgt ggtccggctg 9960 agcgcctact cgctgggcgg gttcgcagcg gagtggctgt cgcaggagta ctttcacaga 10020 cagaggcaca actcctttgc agatttcctt caggcacacc tgcacacggc agacctggag 10080 cgccacgcca tcttcacaga gatcaccact ttctccaggc tgctaacaag tcacgactgt 10140 gaaattttag aatcagaggt cacaggcagg gctccgaaac ccacactcct gtggctgcag 10200 cagtttgaca ccgagtactc attcctcaaa gaagtccgaa actgtttaac gaatacagcc 10260 aaatgtaaaa tcctcatttt tcagacagat tttgaagatg gaatccgtag cgcccagctc 10320 attgcctcag ctaagtattc tgttataaat gaaatcaaca aaatacgaga aaatgaggac 10380 cgtatcttcg tctatttcat cacaaaactg tcccgggtgg gaagaggaac agcctatgtg 10440 ggcttccacg gagggctgtg gcagtctgtc cacatcgatg acctccggag atccaccctc 10500 atggtttctg atgtgaccag gctgcagcat gtcaccatca gccagctgtt cgcgcccgga 10560 gacttgcctg agctgggctt ggaacaccgg gcggaagacg gccatgagga ggcgatggag 10620 acggaggcca gcacatcagg ggaggtggca gaggtggcag aggaggccat ggaaacagaa 10680 agttctgaga aggtgggaaa ggaaacctct gaactcggag gcagtgatgt gtcgatcctg 10740 gacaccacca ggctgctgag aagctgtgtg cagagcgccg tgggcatgct cagagaccag 10800 aacgagagct gcacgcgcaa tatgcggagg gtggtgctcc tcctgggcct cttgaatgag 10860 gatgacgcgt gccacgcctc tttcttgcgg gtatccaaga tgcgcctcag tgtcttttta 10920 aagaagcaag aagagagcca gtttcaccct ctggagtggt tggcaaggga agcctgcaac 10980 caggacgctc tccaggaggc gggcacattc aggcacaccc tctggaagcg ggtccaaggt 11040 gctgtcaccc ctctgctggc gagcatgata tcattcatcg acagagacgg caacctagag 11100 ttactgacca ggccagatac tccgccctgg gcaagagatc tttggatgtt tattttcagt 11160 gacacgatgc ttctgaacat tcctcttgtg atgaataatg aaagacataa aggtgagatg 11220 gcctacatcg tggtgcagaa ccacatgaac ctttccgaga acgcttccaa caacgtccct 11280 ttcagctgga aaatcaagga ctatctggag gagctgtggg tccaggctca gtacatcaca 11340 gacgcagaag gactgcccaa gaagttcgtg gacatctttc agcagactcc tctgggcagg 11400 tttcttgccc agctccatgg agagccgcag caggaacttc ttcagtgtta cttgaaggat 11460 ttcattctct tgaccatgcg tgtgtcaacg gaggaggaat taaagtttct gcagatggct 11520 ctgtggtcct gcactaggaa actgaaagcg gcgtcagaag cgcccgagga agaggtttcc 11580 ttaccgtggg tgcaccttgc ctaccagcgt ttcagaagcc gtctgcagaa cttttccaga 11640 atcctgacca tctaccctca ggttctccac agcctgatgg aagcccgttg gaaccatgag 11700 ctggctggat gtgagatgac cctggacgca tttgccgcaa tggcctgcac ggagatgctg 11760 acaagaaaca ccctgaagcc cagtccccag gcgtggctac agttggtgaa gaatctttcc 11820 atgccgctgg agctcatctg ctccgatgag cacatgcaag gcagcgggag cctggcccag 11880 gctgtcatca gggaagtcag agcccagtgg agtcggattt tctccaccgc actcttcgtg 11940 gagcacgtgc tcctaggaac cgagagccgc gtccccgagt tacaggggct ggtgaccgag 12000 cacgtcttct tactagacaa gtgtcttcga gagaactctg acgtgaagac gcacgggcct 12060 tttgaggccg tgatgcgcac tctctgtgaa tgcaaggaga cagccagcaa gaccctcagc 12120 aggtttggga ttcagccgtg ctccatctgc ctgggagatg caaaggaccc cgtctgtctg 12180 ccctgcgacc acgtgcactg cctgcgctgc ctcagggcct ggtttgcctc agagcagatg 12240 atatgcccct actgtttaac tgccttgcca gacgaattct ctccagctgt ttcccaagcg 12300 cacagggaag ccattgaaaa gcatgcccgc ttccggcaga tgtgcaacag tttcttcgta 12360 gacctggtgt ccaccatttg cttcaaggac aacgctccgc ctgagaagga agtgattgag 12420 agcctgctct ctctcctctt cgtccaaaag gggcgcttaa gagatgctgc ccagagacac 12480 tgtgaacaca caaaatctct ctctccattc aatgatgttg tggataagac tcctgtcatc 12540 cgctcagtga tactgaaact gcttttgaag tacagctttc atgatgtaaa agattatatt 12600 caggaatatt tgaccctgtt aaaaaagaaa gcattcataa ctgaagataa aactgaactg 12660 tacatgctct tcatcaactg cctggaggat tcaatacttg agaagaccag tgcttactcc 12720 agaaatgatg aactgaacca cctagaagag gaaggtcgtt tccttaaggc atattctcca 12780 gcaagccggg gccgagagcc tgccaacgag gcctcggttg aatacctgca agaggtggcc 12840 cggatccgcc tctgcctcga cagagctgca gatttcctct cggagcctga gggaggccca 12900 gagatggcca aggagaagca gtgctacctg cagcaagtca agcagttctg tatccgggtg 12960 gagaacgact ggcaccgggt gtacctggtg cggaagctca gcagccagcg ggggatggag 13020 ttcgtgcagg gcctctccaa gcccggccgc ccgcaccagt gggtgtttcc caaggacgtt 13080 gtcaagcagc aggggctgcg gcaggaccac ccaggccaga tggataggta cctggtgtac 13140 ggcgatgaat acaaggctct ccgtgatgct gtggccaaag ctgtcctcga gtgcaagcca 13200 ctgggcatta agactgctct gaaggcctgc aagacccccc aaagccagca gtcagcctac 13260 ttcctgttaa cactgtttag agaggtggct attttgtaca gatcccacaa tgcaagcctc 13320 caccccacgc cagagcaatg tgaagctgtg agcaaattca ttggcgaatg caagatcctt 13380 tcacctcctg atatcagccg ttttgcaaca tcgctcgtgg acaattctgt gccattgttg 13440 agggcggggc ctagtgacag caaccttgat ggaacggtga cagaaatggc cattcatgct 13500 gcagccgtcc ttctgtgtgg acagaatgaa ctcttggagc ccctaaagaa tctggccttc 13560 tccccagcca ccatggcgca tgcttttctt ccaaccatgc ctgaagactt gctggctcaa 13620 gctcggaggt ggaagggtct ggagcgagtc cactggtaca cttgtcccaa cggccatcct 13680 tgctccgtgg gagagtgtgg caggccgatg gaacagagca tctgcattga ctgccatgcg 13740 ccgattggag gcattgacca caaacctcgg gacggctttc atctggtcaa agacaaggca 13800 gacagaacgc agaccggcca cgtgctgggc aacccgcagc ggagagacgt ggtgacatgt 13860 gaccgagggc tgcccccagt ggtcttcctc cttatccggc tactcactca cttggctctg 13920 cttctgggag cgtcccagag ttcccaggct ctgataaaca tcattaagcc tccagtgagg 13980 gatccaaaag gctttctgca gcagcacatc ctgaaggacc tggagcagtt ggccaagatg 14040 ctgggacaca gtgccgacga gaccatcggc gtggtccacc tcgtcctgcg caggcttctc 14100 caagagcagc accagctctc tagcagaagg cttttaaatt ttgacacaga attgtcaact 14160 aaagaaatga ggaacaactg ggaaaaggaa atcgcagctg tgatttctcc tgaactggag 14220 catctagata aaacccttcc caccatgaat aatctcatca gccaagataa gcgtatcagc 14280 tctaaccctg tggccaaaat aatatatggt gacccagtga ccttcctgcc ccacctgccc 14340 cggaaaagtg tggtccattg ctctaagatt tggagctgca ggaaaagaat tacagttgag 14400 tacctccagc acattgtgga acagaaaaat ggcaaagaaa gagtgcccat cctctggcat 14460 ttcctgcaga aggaagcaga gctgaggctg gtaaagttcc tgcctgagat tttggccttg 14520 caaagggatc tagtgaagca gttccagaac gtccagcaag ttgaatacag ctccatcaga 14580 ggcttcctca gcaagcacag ctcagatggg ttgaggcagc tgcttcacaa caggatcaca 14640 gtctttctgt ccacatggaa caaactgagg agatcgcttg agacgaacgg tgagatcaac 14700 ctacccaaag actactgcag cactgacttg gatctggaca ctgagtttga gatcctcttg 14760 ccacgccgac ggggcctggg cctctgtgct accgctctcg tcagctactt gattcgccta 14820 cacaatgaaa ttgtctacgc cgtggaaaaa ctctccaagg aaaacaacag ctattccgtg 14880 gatgccgccg aggtcactga actgcatgtc atcagttatg aagtggagcg ggacctgact 14940 ccactgattc tctccaactg ccagtaccag gtggaggagg gcagagagac cgtgcaggag 15000 ttcgatctgg agaagattca gcggcagatc gtcagccgct tcctccaggg caagccccgg 15060 ctgagcctca agggaatacc cactctggtg tacagacacg actggaacta tgaacatctc 15120 tttatggaca tcaagaacaa aatggcacag gactccctcc ccagctcggt cattagtgcc 15180 atcagtggac agctgcagtc ctacagcgat gcctgtgaag tgctgtctgt cgtagaagtc 15240 actctggggt ttctgagcac agctggtggg gatccaaaca tgcagctgaa tgtgtatact 15300 caagacatcc tgcaaatggg tgatcagacg attcacgtgt taaaggcctt aaacagatgc 15360 cagttaaaac acaccattgc cctctggcag ttcctgtctg ctcataagtc tgaacagctg 15420 ctgcggctgc acaaagagcc atttggggaa atcagttcaa ggtacaaagc ggatctgagc 15480 ccggaaaatg ctaagctcct cagcacattc ctaaatcaga ctggcctaga cgccttcctg 15540 ctagagctgc acgaaatgat aatcttgaaa ctaaagaacc cccaaaccca aaccgaggag 15600 cgcttccgcc ctcagtggag cctgagagac actctcgtaa gttacatgca aactaaagaa 15660 agtgaaattc ttcctgaaat ggcatctcag ttcccagaag agatactgct cgccagctgt 15720 gtctcagtgt ggaaaacagc tgctgtgctg aaatggaatc gagaaatgag atagaattat 15780 ttcctcagct atctttggat gactttggag agaagactcc tctctcctcg tctgcggcgt 15840 ggacttgatc atggactggt gcctttgcat tcagaaggag agctgtcagc gtagcaccga 15900 attcaagacc aaggcgtgct acctgagctg acagcttttt gaaagccgag ctgtttctga 15960 accatgtaca tacatgttct gaaactttct catcatttta tgagtactgt tcattgagag 16020 atgacaatga agattagatg aaattggaaa taaaccaaca ttgtttacat tccaggagac 16080 ttgtagctca gccacacacg cagtaatgac ctgtgcccgt tcgcctctgg cactgcccac 16140 ccctcttttt ttttttcttc taattctgta ctcacaaaag agaatctcat tttcttcttt 16200 cttccattcc cttaaattct gagtactgta catatatttc tgggttccca cgatgatgtg 16260 aaaaactacc agactgtttt ttgtcttctc acaaagacaa gaaaaatcag ggcattttgt 16320 gagtgcctta agatcaaact aacaagatct gaccctctcc cctcacagtg agccactgcc 16380 ccacttcaga gggtaagagc caaaagcctc attgtgaaag gcactggact tggaccaggg 16440 acaccatcag ggccttggtt ttctcacgca taaaatggag agtggattaa tcgccaaaga 16500 ttcttctgat ctgacatttt gaaattgtga gagaaactag atgactgtaa acttggtcac 16560 aggcctggtt ctggcagttc tttgcggact tttttctagc attatgccaa ataaacatgc 16620 agtctcagtg tgctctcgca tgtatgaata tctagtcctt tctgtggttc tcagccaaga 16680 cataaaaact aggactcaga gcacatacaa aaccagttat gtttcggaaa gagggaaaag 16740 agtccccgag cccggatctt gtgctgcttt tctcactgac gtgttgcctt ttttctttac 16800 aaaatctgct ttgatactta ggacctctct ggactaattt ctcttcctag acagctcagc 16860 acagctattg atatgttaga ggcagtatcc ttaatattca ttctaaatga gttaacgact 16920 taacttgaaa ttgggcctaa ggagtgagaa ctacaaaaat acaaaatgct tgtccaggac 16980 tcagccatgc acaccttgag cagcgccggc aggaggcacg gaaggaactg tgctccgttc 17040 tcctcactgt catggtgcca ccagtgtctg atgaagggca gagtgaccca gactgcaggc 17100 agtaactgac ttcacacagt ccctggcatt tagtcatctg tgattgtttt atcactctgg 17160 actgtgcaga gccacctgcc accgagatct gcattccgac tgcctatgaa cgggtgtggg 17220 ggccgggggc tggcttgctg aagtcttcaa cttgcactcg gagctccttt gatacctcag 17280 agctggctgt caggtggcag ctcacaccca gactcactgg ccacacctca gcaggggggg 17340 agtcgagtgt cagtctcttt ctgtgaaggc tttttttttc ctttggcctg ggaatttttc 17400 ccatttttat gaaggggttt taaattgttt cattttgtgt gctgtgcttc aaagccttaa 17460 ctgtcaaatc ttgcattatc ttgtttgtac agaaatatac tggcctagca gaggcaaaaa 17520 aaaaaaaaat gaattttatt ttacttgtca cacctgtctt aataaactgg agttttgctg 17580 ctaaagaact cttctctctg ggggcagagc ttctatttat ggcacataga catcagctag 17640 gcttttggga atcgtttgtg ttctttgtgg aaatgtcctt tagaagcacc catgaagtag 17700 tgtgttcaga ctgtgcacac agaaaacagg ctctgccttc acatgtgaga cggtggactt 17760 ttcctctgga caaaatgaca gcatcctggc gactccacag tggagctgag cgccactccc 17820 tgtagccgat ctgggactga aacgcttaca cctctgcctc agaaggagtc ccccatgccc 17880 tgcctgaaat gacttcactg gacacagcgg ggctgcagct aacggggtac aggtaggagc 17940 taactaactt cacccctgag tccacttgcg gggtaagaga taaacagtaa cccttccagg 18000 agcccactga cgttggagtg ctaaaaatgc cccttcaggg ggaaaactgc attttctctt 18060 ccaaaaagga aaggttcttc caggcgagaa acctgtggtc tagaaccaca gcaagaagag 18120 gaggcatgct ggcctgcacc ggaagactca ctttgtctgc cctgcgccag cctcacctca 18180 ccctgcagtt cccgtttccg ccatggatgc ctcatcacca accctgacct tccccctccc 18240 aaccctttat tcatcctcac tcccactcat acccgcctcc ctggacagtt ccctgctgca 18300 gagttctttc tgctttcagc cctaccttgg tggtgattta cctgaaaatc ttcacaactg 18360 atcattatct ccttctcttt gagacctgac tgaaaaaatt aggtgtgcac acctgtaatc 18420 ccagctacct gggaggctga ggtatgagga ttgcttgagc ctgggagttt gaggctgcag 18480 tgagctatga ttgcaccact gcactccaac ctgggtgaca gagtgagacc ctgtctcaaa 18540 aaaaaataaa ataaggacct tattgtgtgt gcaaattatt tgcctttcat gaatagttat 18600 gagactttgt gcatgtgtta accgagacgg ccctgagcta tttcagttac tcctgtatgt 18660 tcaggcaatt ccaatttaga aacaaacttc cagtgataaa tattgggaag aaaatgtcag 18720 ctcagggcca agtaggtaaa gccacccaag tctagccatg cacacaggca ctagtgtgct 18780 gaaggaaaac acctctgatt tgatacataa agtgtgaagg ttgcataact ggggaggtgg 18840 ctggagaaaa cctgagcctc gagctgagta acaatccaag ccatgattag catttatatt 18900 gcattctgca ttattctcat cctatcacgt tcattaagtt caaccattac cattacgaat 18960 cccgtttcca gctggaaaaa caagcgccag gaaagtgcat ttccccccca cccccccccc 19020 ccaaccagag caactttggt cagaagtcac acctaatcac cctctctgca ggatatgctg 19080 gggatagccc ttttgaggag gtgggggtgt atgcgaaagc aacctggggc caaagcaggg 19140 ggaagcagga gagactggag gggccctggg tccagcaagt gctccaccag gctgcccctg 19200 ctcaggtgct ccacagccca taaaaaacgc cttcagccct gctgtgcttc ccctcacacc 19260 taaacttact ataagggtcc taccttcccc agtattcctt catgatcact gctacctgtg 19320 ccctgaagcg caacagaacc tcaacccaga ggacagccac ttcctcagaa cccacgatct 19380 ttgccccatc gccacaggtc catgagtgac tcctaattac caaatccaag ggctccttca 19440 ccctgaccac tctggaaccc aacaaagctg acacacagcc cagcccagac aggcctgaat 19500 gtgggtcctg gctctcccat ttgccagttc tacagccatg ggcaagtggc tcgacctctc 19560 taagcttcag tttcctcgtc tgtgaaatat ctgtcagtgc tcttaaggga ggagaccacc 19620 ccacatattg tcttacgccc aatttctgcc tccaaagaga gaagtaaaaa ctaaaaggca 19680 gaaatgaaat ccacaagcag acagcctgca ccacaccctg ggcctggtag ttaaagatcg 19740 acgcctgacc taatcagtga tgctatctat agattacaga cattatatag aaaagcaccg 19800 tgaaaatccc tgtcctgttc tgttccgttc taattacggg tgcatgcagc ccccagtcac 19860 gtaccccctg cttgctcaat caatcacgac cctctcacgc agacccctta agagttgtga 19920 gcccttaaaa gggacaggaa ttgctcactc ggggagctca gttgttggag acatgagtct 19980 tgccgaagcg cccggctgaa taaagccctt ctttaactcg tgtctgaggg gttttctctg 20040 cagcttgtcc tgctacattt cttggttccc tgaccaggaa tctaggtgat taatggatgg 20100 ttgaggcagc ccctcagacg gcttaggcct gccctgtgga gcatccctgt ggaggactcc 20160 agccagcttg agcgacatgg atcctgagag cgctctcagg caggcaattg ccccagtgga 20220 atgcctggcc agagcagtgt gtagcaggcc cccgaggagg atcaacgcag tggctgaaca 20280 ccgggaagga actgccactt ggagtccaga catctgaaac ttggtaagac tggtctttgg 20340 aacttgccca ctccatttga ggggaagcgt ggcctgatca cccacggcgt gcctgtactg 20400 gcactctggt ttttgttttt gacttgactt ggattgcttg atactttggt tttggttttg 20460 acctgacttg gatatcctga tactctgatt ttggttttga ttttggtttg gtgtaaactg 20520 taaaagtgtg tgtgtgccct ttttacctgt tctttgtttt gtggtatgcg tgtagggtga 20580 gcgtaatgtt ttgtcttgaa gaagcatggg tcaagcacaa agtaagacca ccccactagg 20640 aactatgctg aaaaatttca ggaaaggatt taagggagac tatggagtac tatgacacca 20700 ggaaaactta aaactttgtg taagatagac tggccagcat tagaggtagg ttggccatca 20760 gagtgaagcc tggacaggtc ccttgtttca aaggtatggc acaaggtaac ctgtaagcca 20820 gggtacccac accagttccc gtacacagac acttggttac agctggtttt agactcccca 20880 cccgcccgcc ccaacagtgg ttgagagaac agcagcataa gtggctggca gaggcaagga 20940 aagaccagca gagagagaaa gaggaagaga cagacaaaga gggagtcaga gagagagaga 21000 gaaagagaca gaggcaaaag gaaagtcaaa gagaaagaga cagaaaatca agaggaaaaa 21060 aa 21062 <210> 6 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> RNF213-CF primer <400> 6 actgggtggt cttcccttct 20 <210> 7 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> RNF213-CR primer <400> 7 gaaggagtga gccgagtttg 20 <210> 8 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> F1 primer <400> 8 agcaagttga atacagctcc attaa 25 <210> 9 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> F2 primer <400> 9 agcaagttga atacagctcc attaaa 26 <210> 10 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> F3 primer <400> 10 gcaagttgaa tacagctcca tgaa 24 <210> 11 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> F4 primer <400> 11 caagttgaat acagctccaa caa 23 <210> 12 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> F5 primer <400> 12 caagttgaat acagctccac caa 23 <210> 13 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> F6 primer <400> 13 caagttgaat acagctccag caa 23 <210> 14 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> R1 primer <400> 14 ccctatgcag tgatcctttc g 21 <210> 15 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> ZEN probe <400> 15 accaggactg tcccgcattt ggc 23 <210> 16 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> RNF213_Zen F1 primer <400> 16 cagttccaga acgtccagca a 21 <210> 17 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> RNF213_Zen F2 primer <400> 17 gttccagaac gtccagcaa 19 <210> 18 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> RNF213_Zen R1 primer <400> 18 tttcgaaccg ccaaatgc 18 <210> 19 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> RNF213(ZEN-A1) probe <400> 19 aatacagctc catcaaaggc ttcctca 27 <210> 20 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> RNF213(ZEN-A2) probe <400> 20 cagctccatc aaaggcttcc tca 23 <210> 21 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> RNF213(ZEN-G1) probe <400> 21 ttgaatacag ctccatcaga ggcttcc 27 <210> 22 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> RNF213(ZEN-G2) probe <400> 22 cagctccatc agaggcttcc 20 <110> Samsung Life Public Welfare Foundation          BIOSEWOOM, INC. <120> Composition for diagnosing diseases caused by mutation of RNF213          gene using Real-Time PCR, and use thereof <130> PN115412KR <160> 22 <170> KoPatentin 3.0 <210> 1 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> RNF-MGB F1 primer <400> 1 agaacgtcca gcaagttgaa taca 24 <210> 2 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> RNF-MGB R1 primer <400> 2 tttcgaaccg ccaaatgc 18 <210> 3 <211> 14 <212> DNA <213> Artificial Sequence <220> &Lt; 223 > RNF213 (A) probe <400> 3 ctccatcaaa ggct 14 <210> 4 <211> 13 <212> DNA <213> Artificial Sequence <220> &Lt; 223 > RNF213 (G) probe <400> 4 ctccatcaga ggc 13 <210> 5 <211> 21062 <212> DNA <213> Homo sapiens <400> 5 ggggcgacag cgcgcggcag gcggcgagct cgggggccgc agaaaatgaa actgaagccg 60 tggtcacgtg acaggacatg tagtatatag caggctgcca gcgactcctg ctcttgcttc 120 tggatctgca gggcagtccc agcaggaccc atggagtgtc cttcgtgcca gcatgtctcc 180 aaggaggaaa cccccaagtt ctgcagccag tgcggagaga ggctgcctcc tgcagccccc 240 atagcagatt ctgagaacaa taactccaca atggcgtcgg cctcggaggg tgaaatggag 300 tgtgggcagg agctgaagga ggaagggggc ccgtgcttgt tcccgggctc agacagttgg 360 caagaaaacc ccgaggagcc ctgttccaaa gcctcctgga ccgtccaaga aagcaaaaag 420 aagaaaagga agaagaaaaa gaaggggaac aagtccgctt cctcagagct ggcttccttg 480 cccctttctc ctgccagccc ctgtcacctg actttgcttt caaacccgtg gcctcaggac 540 acagccctgc cccacagcca agcccagcag agtggcccca ctggccagcc gagccagccc 600 ccaggcacag ccaccacgcc actggagggt gacggcctct ccgcgcccac cgaggttggc 660 gacagccccc tgcaggccca ggctttggga gaggcaggag tggccacagg aagtgaggct 720 cagagcagcc cgcaattcca ggaccacacg gaaggggagg accaggacgc ttccatcccc 780 tctgggggca gaggcctgtc ccaggagggg accggtcccc ccacctctgc tggtgaaggc 840 cattctagga ctgaagatgc tgcccaggag ctcctgttgc ctgagtcaaa aggaggcagc 900 tctgagcccg ggacagaact gcagaccacc gagcaacagg caggggcctc agcctctatg 960 gcagttgatg ctgtagctga gccagccaat gcagttaaag gggccgggaa ggaaatgaaa 1020 gagaagaccc agagaatgaa acagccacca gcaaccactc ctcctttcaa aacacactgc 1080 caggaagctg agaccaagac caaggacgag atggctgctg ctgaagaaaa agtcggtaag 1140 aatgaacaag gggagcctga agacctcaag aagccagagg ggaagaacag aagtgcagct 1200 gctgtgaaaa acgagaagga gcaaaaaaac caggaagcag atgtccagga agtgaaggca 1260 agcacgctga gcccgggtgg aggagtcacc gtgttcttcc acgccatcat ctctcttcat 1320 ttcccattca atcctgacct ccataaagtc ttcatcagag gaggagaaga atttggggag 1380 tcaaaatggg acagcaatat ctgtgagctg cactacacca gagacttggg tcatgaccgc 1440 gttcttgttg aaggcattgt ctgcatttcc aagaagcacc tagataaata cattccttac 1500 aagtacgtca tttataatgg ggaatctttt gagtatgagt tcatttacaa gcaccagcag 1560 aagaagggcg agtacgtcaa ccgctgtctg ttcataaaat cttcacttct gggctcagga 1620 gactggcatc agtactatga catagtttat atgaagcctc atgggagact ccagaaagtc 1680 atgaaccaca tcacagacgg gccgaggaag gacctggtga aggggaagca gattgccgct 1740 gcgctcatgc tggacagcac cttcagcatc ctgcagacct gggacaccat caacctgaac 1800 agcttcttca cccagttcga gcagttttgc tttgtcctgc aacagcctat gatttatgaa 1860 ggacaggcac agctgtggac cgatttgcag tacagggaga aagaggtgaa gagatacctg 1920 tggcaacatc tgaaaaaaca cgtggtacca ttgccggacg gaaaaagcac ggactttttg 1980 cctgtggact gcccagtgag gagtaaactg aaaacaggcc tgattgtcct ttttgtagtg 2040 gaaaaaattg agcttttatt agaaggcagc ctggactggt tgtgtcacct cctaacctca 2100 gatgccagct caccagatga gtttcaccgt gacctaagcc acatccttgg gatacctcag 2160 agctggcggc tgtacctggt gaacctgtgc caaagatgca tggacacaag gacgtacacc 2220 tggctgggcg ccctgcctgt cctgcactgc tgtatggagc tggccccgcg gcacaaggat 2280 gcctggagac agcctgagga cacctgggcc gctctggagg gactctcctt ctcaccgttc 2340 cgggaacaaa tgctagatac gagttcccta cttcagttta tgagagagaa gcagcatttg 2400 ctgagcatag acgagcctct cttccggtcc tggtttagtc tgctacctct gagtcacctg 2460 gttatgtata tggaaaactt cattgagcac ctgggtcgtt ttcctgctca tatcctggac 2520 tgtctttcag ggatttacta ccggcttccg ggacttgagc aagtcttgaa tacgcaggat 2580 gttcaggatg ttcagaacgt tcagaacatt ttagaaatgc tgttgcgact cctggacact 2640 taccgggaca agattcccga ggaggccttg tcaccatcct acctgactgt gtgtctgaaa 2700 ctgcatgaag ccatctgcag cagcacaaag ctacttaagt tttacgagct gccagcctta 2760 tctgccgaga ttgtctgcag aatgattaga cttctatctc tggtggattc tgcaggacag 2820 agagatgaaa ctggaaataa ttcagtccaa acagtcttcc aagggaccct tgctgctacg 2880 aaaaggtggc tccgagaagt ttttacaaag aacatgctca catcttcagg tgcctcattc 2940 acatacgtca aggaaattga ggtctggagg cggctggtgg aaatccaatt ccccgcggag 3000 catggctgga aggagtcgtt gctgggagac atggaatgga ggctcacaaa ggaggaaccc 3060 ctctcccaga tcactgccta ctgcaatagt tgctgggaca ccaaaggctt agaggacagt 3120 gtggccaaga ccttcgagaa atgcatcatt gaagccgtga gctcagcctg ccagtctcag 3180 accagtatcc ttcaggggtt ctcttactct gatttgcgga aatttggcat cgtcttgtct 3240 gctgtgatca ctaagtcctg gcctaggacc gcggacaact tcgatgacat tttaaagcat 3300 ctgctcacgt tggcagatgt caagcacgtc ttcagattgt gtggaaccga cgagaaaata 3360 ctagcaaatg tcacagagga tgccaagagg ctgatagctg ttgccgactc tgtgttgacg 3420 aaagttgttg gtgacctcct aagtggcacg attttagttg gacaactgga gctgattata 3480 aagcacaaga atcagtttct tgacatctgg caactgaggg aaaaaagtct ttcaccccag 3540 gatgaacaat gtgctgtgga ggaagcactg gattggagaa gggaggaact gttacttcta 3600 aagaaagaga aaagatgtgt tgatagtctc ctgaagatgt gtgggaacgt gaaacatctg 3660 atacaagtgg actttggagt gcttgcagta agacactcac aagacctcag cagtaaaaga 3720 ttaaatgaca ccgtgacagt gagactgtcc acctcctcga actcgcagag ggcaacgcat 3780 taccacctga gctcccaggt ccaagaaatg gctgggaaga tagacttgct cagagacagc 3840 cacatcttcc agctcttctg gcgggaagcc gcagagccgc tgagtgagcc taaggaggac 3900 caggaagccg cagagttgct gagtgagccc gaagaagaat cagaaaggca catccttgag 3960 cttgaagagg tgtatgacta tttgtatcag ccttcttaca gaaagttcat taagttgcac 4020 caggatctaa agtcaggaga ggtcaccctt gcagagattg atgtcatctt caaggacttt 4080 gtgaataaat acacggacct ggattcagaa cttaagatca tgtgcaccgt ggaccaccag 4140 gaccaaagag attggatcaa ggaccgagtc gaacagatca aggaatacca tcacctgcac 4200 caggctgtcc acgcagccaa ggtcatcttg caggtcaaag agagcctggg actgaacggt 4260 gacttcagtg ttctcaacac tttactaaat tttactgata acttcgacga ctttcgccgt 4320 gaaacactgg accagatcaa ccaggagctc atccaggcca aaaagctgct ccaggacatc 4380 agcgaggccc ggtgcaaggg gctgcaggct ctgtccctga gaaaggagtt catctgctgg 4440 gtccgggagg ctcttggagg catcaatgag ctgaaggtgt ttgtggacct ggcctccatc 4500 tcagcggggg agaatgacat tgatgtggac cgggtggcct gcttccatga cgctgtgcag 4560 ggctacgcat ccctgctatt taagctggac cccagcgtgg acttcagtgc attcatgaag 4620 catctgaaaa agctgtggaa ggctctggat aaggaccagt acctgcccag gaaactgtgt 4680 gactccgcca ggaacttgga atggctgaag actgtgaatg agagtcatgg gtctgtggaa 4740 cgctcatccc tgaccctggc cacggccatc aaccaaagag gcatctatgt gatccaggcg 4800 cccaaaggtg gccaaaagat ttccccagac acggttctgc acttgatcct tcctgagagc 4860 cctggcagcc acgaggagtc acgagagtac tctttagagg aggtgaagga gcttttgaac 4920 aagttgatgc tgatgtctgg caagaaggat cgtaacaaca cggaagtgga gaggttttca 4980 gaggtcttct gcagtgtgca gaggctcagc caggccttca tcgacctgca ctctgctggg 5040 aatatgctgt tcaggacgtg gatcgccatg gcctactgct cccccaagca gggtgtgtcc 5100 ctccaaatgg actttggctt ggacctggtg acggagctta aagaaggtgg agatgtcact 5160 gagctgctgg cagccctctg caggcagatg gagcacttcc ttgacagctg gagagattt 5220 gtgacccaga agcgaatgga gcacttttac ctgaacttct acacggcaga gcagctggtt 5280 tacctgagca ctgagctcag gaagcagccc ccgagtgatg ccgccctaac gatgctatcc 5340 ttcatcaaaa gcaactgcac cctgagggat gtcttaaggg cctctgtggg gtgtgggagt 5400 gaggccgcca ggtaccgcat gaggagagtc atggaagagc tcccgctgat gctcttatca 5460 gagttcagcc tggtggacaa gctgaggatc atcatggagc agtccatgag gtgccttcct 5520 gccttcctgc ccgactgcct cgacctagag acccttggcc actgtctggc tcacctggca 5580 gggatgggtg ggtctcccgt ggagcgttgt ctcccgagag gtctgcaggt cggccagccc 5640 aacctcgtcg tctgtggcca ctccgaggtg ttgccagccg ccctggctgt ctacatgcaa 5700 accccaagcc agcccctgcc cacttacgat gaggtgctgc tctgcacccc ggcaaccacc 5760 tttgaggagg tggcactgtt gctgcgccgc tgcctgaccc tgggctccct ggggcacaag 5820 gtctacagcc tgctgttcgc agatcagctg agctacgagg tggcacgcca agcggaggag 5880 cttttccaca atctgtgcac gcagcagcac cgagaagact accagctcgt catggtctgt 5940 gatggggact gggagcactg ctacctcccc tctgccttca gccagcacaa ggtcttcgtc 6000 accccccagg cacccctcga ggccatccaa gcctacctgg caggtcacta ccgggtcccg 6060 aagcagaccc tgtcggcggc agccgtgttc aatgaccggc tgtgtgttgg gatcgtggcc 6120 tcggagcgag caggtgttgg aaagtctctg tacgtgaaga ggttgcacga caaaatgaag 6180 atgcagttaa acgtgaaaaa tgtgcctctg aaaacaattc gactgatcga ccctcaggtg 6240 gatgagagcc gagtcctggg cgccctgctg cccttcctgg atgcgcagta tcagaaggtc 6300 cccgtgctct ttcacctgga cgtgacctcc tcagtgcaga ctggaatttg ggtgtttctt 6360 ttcaagctcc tcattttaca atacttaatg gatataaatg ggaaaatgtg gcttcggaac 6420 ccctgccatt tgtatatcgt tgaaatcctg gaaaggagga cgtcagtgcc gtcgaggagc 6480 tcttcagcgc tgcgtacacg tgtaccccag ttcagttttc ttgacatctt cccaaaagtc 6540 acctgcaggc ctcccaaaga ggtgatagac atggagctga gtgccctgag gagtgacaca 6600 gagcctggga tggatctgtg ggagttctgc agcgaaactt tccaaagacc ttaccagtat 6660 ttaagacgat tcaatcaaaa ccaagaccta gacacgtttc agtatcaaga aggctctgtc 6720 gaaggcaccc cggaggaatg cctccagcat ttcctgtttc actgcggggt aataaaccca 6780 tcctggtcag agcttcggaa ctttgctcgg ttcctgaatt atcagctcag agattgtgag 6840 gcctctctct tctgcaatcc gagttttatt ggcgacacac tgaggggctt caagaagttc 6900 gtggtgacct tcatgatctt tatggcaaga gattttgcca caccatcact ccacacctct 6960 gccaaagcc cggggaagca catggtcacc atggatgggg ttagggaaga agatctagcg 7020 cccttctccc tccggaagag gtgggagtcg gagcctcacc catacgtttt cttcaatgac 7080 gaccacacaa ccatgacatt catcggcttc catctgcagc ccaacatcaa cggcagtgtc 7140 gatgccatca gtcacttgac tgggaaggtc atcaagagag acgtcatgac cagggacctg 7200 taccagggcc tgctgctcca gagggtgccc ttcaatgtcg actttgataa actgcccaga 7260 ccaagaaac ttgagaggct ctgcctgacc ttagggatcc cccaggccac cgaccccgac 7320 aaaacgtatg agctcacaac cgacaatatg cttaaaatcc ttgccatcga gatgcggttc 7380 cggtgtggga tcccggttat catcatggga gaaactggct gtgggaaaac caggcttatt 7440 aaattcctta gcgacctgcg gcgtggtggt accaatgctg acaccataaa gctggtcaag 7500 gtgcacggag gaacaactgc agacatgatc tactccagag tcagggaggc tgaaaatgtg 7560 gccttcgcca ataaggacca acatcagttg gacaccatct tgttttttga tgaagccaac 7620 acaacggaag ctataagctg tatcaaagaa gtcctgtgtg atcatatggt ggatggccag 7680 cctctggctg aggactctgg cctgcatatt atagctgcct gcaatccata ccggaagcac 7740 tctgaggaga tgatctgccg tttggagtca gctggtttgg gctacagggt tagtatggag 7800 gagacggccg acaggctggg ctccattcct ctgaggcagc tggtataccg ggtccatgct 7860 ctgcccccga gcctgattcc tctggtgtgg gactttggac aactgagtga cgttgctgaa 7920 aagctctaca tccagcagat tgtccagaga ctggttgagt ccatcagcct agatgaaaac 7980 gggactcgcg tgatcacaga agtcctctgc gcctctcagg gtttcatgag gaaaacagaa 8040 gatgagtgca gctttgtcag cctcagggac gtggagcgct gtgtgaaagt tttcaggtgg 8100 ttccacgagc acagcgcgat gctcttagcg cagctgaatg cctttctctc caagtccagc 8160 gtcagcaaaa atcacaccga gagagatccc gtcctctggt cgttgatgct ggccatcggg 8220 gtgtgttacc atgcctcttt agaaaagaaa gactcatatc ggaaagccat cgccaggttc 8280 tttccgaaac cgtatgacga cagcaggctg cttctggatg aaataacacg ggcacaggat 8340 ctttttctgg acggcgtacc tctgaggaaa accatcgcca agaacttggc cttgaaggag 8400 aacgtcttca tgatggtcgt ctgcatcgag ctgaagattc ccctcttcct ggtggggaag 8460 cccggcagct ccaagtctct cgccaagacc atcgtggcag acgccatgca gggcccggct 8520 gcctactcag atctcttccg cagcctgaag caggtccacc tggtgtcctt ccagtgcagc 8580 ccgcactcca ccccacaggg catcatcagc accttccggc agtgcgcccg ctttcagcag 8640 gggaaggacc tgcagcagta cgtctctgtg gtggtgttag atgaggtggg gctggcggaa 8700 gactcaccca aaatgcccct gaagactctg cacccgctgc tggaagacgg atgcattgaa 8760 gacgatcccg ccccccacaa aaaggtcggc ttcgtgggca tctccaactg ggcccttgac 8820 cctgccaaga tgaaccgggg catttttgtg tcacgtggca gccccaacga gacagagctc 8880 atagagagcg ccaagggcat ctgctcctca gacatcctcg tccaggaccg agtccaaggg 8940 tactttgcgt cctttgccaa agcctacgaa acggtgtgta agcgccagga caaggaattc 9000 ttcgggcttc gtgactacta cagcctcatc aaaatggtct ttgctgcagc aaaggcttca 9060 aatagaaagc cttccccgca agacattgca caggctgtcc ttaggaactt cagtggcaag 9120 gatgacatcc aagctttgga catctttctg gccaatttgc ccgaggccaa gtgctcagag 9180 gaagtcagcc ccatgcagct gatcaaacag aacatctttg ggccttctca gaaggtgccg 9240 ggtggagagc aggaagatgc tgagtcccgc tacttactcg tgctgaccaa aaactacgtg 9300 gcactgcaga tcctgcagca gacattcttc gagggggacc agcagccgga gattattttt 9360 ggttctggtt tccccaagga ccaagagtac acccagctct gcagaaacat caatcgtgtg 9420 aagatctgca tggaaacagg caagatggtg ttgcttctca acctgcagaa cctctacgag 9480 agcctctacg acgcactcaa ccagtactac gtccacctcg gcggccagaa gtacgtggac 9540 ctcggtctgg ggacccaccg cgtcaaatgt cgggttccc ccaacttccg cctgattgtc 9600 attgaagaga aagacgtcgt gtacaaacac tttcccatcc ccctcattaa ccggctggag 9660 aagcactatc tggatatcaa cacggtgctg gagaaatggc agaagagcat cgtggaggag 9720 ctctgtgcgt gggtggagaa gttcatcaat gtcaaagcac atcatttcca gaagaggcac 9780 aaatacagcc cctctgacgt cttcatcggc taccactcgg acgcctgcgc gtctgtggtg 9840 ctgcaggtca tagagagca gggtccccgg gccttgacgg aggaacttca ccagaaggtg 9900 tctgaggagg ccaaatcgat cctgctgaac tgcgctacgc ccgatgccgt ggtccggctg 9960 agcgcctact cgctgggcgg gttcgcagcg gagtggctgt cgcaggagta ctttcacaga 10020 cagaggcaca actcctttgc agatttcctt caggcacacc tgcacacggc agacctggag 10080 cgccacgcca tcttcacaga gatcaccact ttctccaggc tgctaacaag tcacgactgt 10140 gaaattttag aatcagaggt cacaggcagg gctccgaaac ccacactcct gtggctgcag 10200 cagtttgaca ccgagtactc attcctcaaa gaagtccgaa actgtttaac gaatacagcc 10260 aaatgtaaaa tcctcatttt tcagacagat tttgaagatg gaatccgtag cgcccagctc 10320 attgcctcag ctaagtattc tgttataaat gaaatcaaca aaatacgaga aaatgaggac 10380 cgtatcttcg tctatttcat cacaaaactg tcccgggtgg gaagaggaac agcctatgtg 10440 ggcttccacg gagggctgtg gcagtctgtc cacatcgatg acctccggag atccaccctc 10500 atggtttctg atgtgaccag gctgcagcat gtcaccatca gccagctgtt cgcgcccgga 10560 gacttgcctg agctgggctt ggaacaccgg gcggaagacg gccatgagga ggcgatggag 10620 acggaggcca gcacatcagg ggaggtggca gaggtggcag aggaggccat ggaaacagaa 10680 agttctgaga aggtgggaaa ggaaacctct gaactcggag gcagtgatgt gtcgatcctg 10740 gacaccacca ggctgctgag aagctgtgtg cagagcgccg tgggcatgct cagagaccag 10800 aacgagagct gcacgcgcaa tatgcggagg gtggtgctcc tcctgggcct cttgaatgag 10860 gatgacgcgt gccacgcctc tttcttgcgg gtatccaaga tgcgcctcag tgtcttttta 10920 aagaagcaag aagagagcca gtttcaccct ctggagtggt tggcaaggga agcctgcaac 10980 caggacgctc tccaggaggc gggcacattc aggcacaccc tctggaagcg ggtccaaggt 11040 gctgtcaccc ctctgctggc gagcatgata tcattcatcg acagagacgg caacctagag 11100 ttactgacca ggccagatac tccgccctgg gcaagagatc tttggatgtt tattttcagt 11160 gacacgatgc ttctgaacat tcctcttgtg atgaataatg aaagacataa aggtgagatg 11220 gcctacatcg tggtgcagaa ccacatgaac ctttccgaga acgcttccaa caacgtccct 11280 ttcagctgga aaatcaagga ctatctggag gagctgtggg tccaggctca gtacatcaca 11340 gacgcagaag gactgcccaa gaagttcgtg gacatctttc agcagactcc tctgggcagg 11400 tttcttgccc agctccatgg agagccgcag caggaacttc ttcagtgtta cttgaaggat 11460 ttcattctct tgaccatgcg tgtgtcaacg gaggaggaat taaagtttct gcagatggct 11520 ctgtggtcct gcactaggaa actgaaagcg gcgtcagaag cgcccgagga agaggtttcc 11580 ttaccgtggg tgcaccttgc ctaccagcgt ttcagaagcc gtctgcagaa cttttccaga 11640 atcctgacca tctaccctca ggttctccac agcctgatgg aagcccgttg gaaccatgag 11700 ctggctggat gtgagatgac cctggacgca tttgccgcaa tggcctgcac ggagatgctg 11760 acaagaaaca ccctgaagcc cagtccccag gcgtggctac agttggtgaa gaatctttcc 11820 atgccgctgg agctcatctg ctccgatgag cacatgcaag gcagcgggag cctggcccag 11880 gctgtcatca gggaagtcag agcccagtgg agtcggattt tctccaccgc actcttcgtg 11940 gagcacgtgc tcctaggaac cgagagccgc gtccccgagt tacaggggct ggtgaccgag 12000 cacgtcttct tactagacaa gtgtcttcga gagaactctg acgtgaagac gcacgggcct 12060 tttgaggccg tgatgcgcac tctctgtgaa tgcaaggaga cagccagcaa gaccctcagc 12120 aggtttggga ttcagccgtg ctccatctgc ctgggagatg caaaggaccc cgtctgtctg 12180 ccctgcgacc acgtgcactg cctgcgctgc ctcagggcct ggtttgcctc agagcagatg 12240 atatgcccct actgtttaac tgccttgcca gacgaattct ctccagctgt ttcccaagcg 12300 cacagggaag ccattgaaaa gcatgcccgc ttccggcaga tgtgcaacag tttcttcgta 12360 gacctggtgt ccaccatttg cttcaaggac aacgctccgc ctgagaagga agtgattgag 12420 agcctgctct ctctcctctt cgtccaaaag gggcgcttaa gagatgctgc ccagagacac 12480 tgtgaacaca caaaatctct ctctccattc aatgatgttg tggataagac tcctgtcatc 12540 cgctcagtga tactgaaact gcttttgaag tacagctttc atgatgtaaa agattatatt 12600 caggaatatt tgaccctgtt aaaaaagaaa gcattcataa ctgaagataa aactgaactg 12660 tacatgctct tcatcaactg cctggaggat tcaatacttg agaagaccag tgcttactcc 12720 agaaatgatg aactgaacca cctagaagag gaaggtcgtt tccttaaggc atattctcca 12780 gcaagccggg gccgagagcc tgccaacgag gcctcggttg aatacctgca agaggtggcc 12840 cggatccgcc tctgcctcga cagagctgca gatttcctct cggagcctga gggaggccca 12900 gagatggcca aggagaagca gtgctacctg cagcaagtca agcagttctg tatccgggtg 12960 gagaacgact ggcaccgggt gtacctggtg cggaagctca gcagccagcg ggggatggag 13020 ttcgtgcagg gcctctccaa gcccggccgc ccgcaccagt gggtgtttcc caaggacgtt 13080 gtcaagcagc aggggctgcg gcaggaccac ccaggccaga tggataggta cctggtgtac 13140 ggcgatgaat acaaggctct ccgtgatgct gtggccaaag ctgtcctcga gtgcaagcca 13200 ctgggcatta agactgctct gaaggcctgc aagacccccc aaagccagca gtcagcctac 13260 ttcctgttaa cactgtttag agaggtggct attttgtaca gatcccacaa tgcaagcctc 13320 caccccacgc cagagcaatg tgaagctgtg agcaaattca ttggcgaatg caagatcctt 13380 tcacctcctg atatcagccg ttttgcaaca tcgctcgtgg acaattctgt gccattgttg 13440 agggcggggc ctagtgacag caaccttgat ggaacggtga cagaaatggc cattcatgct 13500 gcagccgtcc ttctgtgtgg acagaatgaa ctcttggagc ccctaaagaa tctggccttc 13560 tccccagcca ccatggcgca tgcttttctt ccaaccatgc ctgaagactt gctggctcaa 13620 gctcggaggt ggaagggtct ggagcgagtc cactggtaca cttgtcccaa cggccatcct 13680 tgctccgtgg gagagtgtgg caggccgatg gaacagagca tctgcattga ctgccatgcg 13740 ccgattggag gcattgacca caaacctcgg gacggctttc atctggtcaa agacaaggca 13800 gaccaacgc agaccggcca cgtgctgggc aacccgcagc ggagagacgt ggtgacatgt 13860 gaccgagggc tgcccccagt ggtcttcctc cttatccggc tactcactca cttggctctg 13920 cttctgggag cgtcccagag ttcccaggct ctgataaaca tcattaagcc tccagtgagg 13980 gatccaaaag gctttctgca gcagcacatc ctgaaggacc tggagcagtt ggccaagatg 14040 ctgggacaca gtgccgacga gaccatcggc gtggtccacc tcgtcctgcg caggcttctc 14100 caagagcagc accagctctc tagcagaagg cttttaaatt ttgacacaga attgtcaact 14160 aaagaaatga ggaacaactg ggaaaaggaa atcgcagctg tgatttctcc tgaactggag 14220 catctagata aaacccttcc caccatgaat aatctcatca gccaagataa gcgtatcagc 14280 tctaaccctg tggccaaaat aatatatggt gacccagtga ccttcctgcc ccacctgccc 14340 cggaaaagtg tggtccattg ctctaagatt tggagctgca ggaaaagaat tacagttgag 14400 tacctccagc acattgtgga acagaaaaat ggcaaagaaa gagtgcccat cctctggcat 14460 ttcctgcaga aggaagcaga gctgaggctg gtaaagttcc tgcctgagat tttggccttg 14520 caaagggatc tagtgaagca gttccagaac gtccagcaag ttgaatacag ctccatcaga 14580 ggcttcctca gcaagcacag ctcagatggg ttgaggcagc tgcttcacaa caggatcaca 14640 gtctttctgt ccacatggaa caaactgagg agatcgcttg agacgaacgg tgagatcaac 14700 ctacccaaag actactgcag cactgacttg gatctggaca ctgagtttga gatcctcttg 14760 ccacgccgac ggggcctggg cctctgtgct accgctctcg tcagctactt gattcgccta 14820 cacaatgaaa ttgtctacgc cgtggaaaaa ctctccaagg aaaacaacag ctattccgtg 14880 gatgccgccg aggtcactga actgcatgtc atcagttatg aagtggagcg ggacctgact 14940 ccactgattc tctccaactg ccagtaccag gtggaggagg gcagagagac cgtgcaggag 15000 ttcgatctgg agaagattca gcggcagatc gtcagccgct tcctccaggg caagccccgg 15060 ctgagcctca agggaatacc cactctggtg tacagacacg actggaacta tgaacatctc 15120 tttatggaca tcaagaacaa aatggcacag gactccctcc ccagctcggt cattagtgcc 15180 atcagtggac agctgcagtc ctacagcgat gcctgtgaag tgctgtctgt cgtagaagtc 15240 actctggggt ttctgagcac agctggtggg gatccaaaca tgcagctgaa tgtgtatact 15300 caagacatcc tgcaaatggg tgatcagacg attcacgtgt taaaggcctt aaacagatgc 15360 cagttaaaac acaccattgc cctctggcag ttcctgtctg ctcataagtc tgaacagctg 15420 ctgcggctgc acaaagagcc atttggggaa atcagttcaa ggtacaaagc ggatctgagc 15480 ccggaaaatg ctaagctcct cagcacattc ctaaatcaga ctggcctaga cgccttcctg 15540 ctagagctgc acgaaatgat aatcttgaaa ctaaagaacc cccaaaccca aaccgaggag 15600 cgcttccgcc ctcagtggag cctgagagac actctcgtaa gttacatgca aactaaagaa 15660 agtgaaattc ttcctgaaat ggcatctcag ttcccagaag agatactgct cgccagctgt 15720 gtctcagtgt ggaaaacagc tgctgtgctg aaatggaatc gagaaatgag atagaattat 15780 ttcctcagct atctttggat gactttggag agaagactcc tctctcctcg tctgcggcgt 15840 ggacttgatc atggactggt gcctttgcat tcagaaggag agctgtcagc gtagcaccga 15900 attcaagacc aaggcgtgct acctgagctg acagcttttt gaaagccgag ctgtttctga 15960 accatgtaca tacatgttct gaaactttct catcatttta tgagtactgt tcattgagag 16020 atgacaatga agattagatg aaattggaaa taaaccaaca ttgtttacat tccaggagac 16080 ttgtagctca gccacacacg cagtaatgac ctgtgcccgt tcgcctctgg cactgcccac 16140 ccctcttttt ttttttcttc taattctgta ctcacaaaag agaatctcat tttcttcttt 16200 cttccattcc cttaaattct gagtactgta catatatttc tgggttccca cgatgatgtg 16260 aaaaactacc agactgtttt ttgtcttctc acaaagacaa gaaaaatcag ggcattttgt 16320 gagtgcctta agatcaaact aacaagatct gaccctctcc cctcacagtg agccactgcc 16380 ccacttcaga gggtaagagc caaaagcctc attgtgaaag gcactggact tggaccaggg 16440 acaccatcag ggccttggtt ttctcacgca taaaatggag agtggattaa tcgccaaaga 16500 ttcttctgat ctgacatttt gaaattgtga gagaaactag atgactgtaa acttggtcac 16560 aggcctggtt ctggcagttc tttgcggact tttttctagc attatgccaa ataaacatgc 16620 agtctcagtg tgctctcgca tgtatgaata tctagtcctt tctgtggttc tcagccaaga 16680 cataaaaact aggactcaga gcacatacaa aaccagttat gtttcggaaa gagggaaaag 16740 agtccccgag cccggatctt gtgctgcttt tctcactgac gtgttgcctt ttttctttac 16800 aaaatctgct ttgatactta ggacctctct ggactaattt ctcttcctag acagctcagc 16860 acagctattg atatgttaga ggcagtatcc ttaatattca ttctaaatga gttaacgact 16920 taacttgaaa ttgggcctaa ggagtgagaa ctacaaaaat acaaaatgct tgtccaggac 16980 tcagccatgc acaccttgag cagcgccggc aggaggcacg gaaggaactg tgctccgttc 17040 tcctcactgt catggtgcca ccagtgtctg atgaagggca gagtgaccca gactgcaggc 17100 agtaactgac ttcacacagt ccctggcatt tagtcatctg tgattgtttt atcactctgg 17160 actgtgcaga gccacctgcc accgagatct gcattccgac tgcctatgaa cgggtgtggg 17220 ggccgggggc tggcttgctg aagtcttcaa cttgcactcg gagctccttt gatacctcag 17280 agctggctgt caggtggcag ctcacaccca gactcactgg ccacacctca gcaggggggg 17340 agtcgagtgt cagtctcttt ctgtgaaggc tttttttttc ctttggcctg ggaatttttc 17400 ccatttttat gaaggggttt taaattgttt cattttgtgt gctgtgcttc aaagccttaa 17460 ctgtcaaatc ttgcattatc ttgtttgtac agaaatatac tggcctagca gaggcaaaaa 17520 aaaaaaaaat gaattttatt ttacttgtca cacctgtctt aataaactgg agttttgctg 17580 ctaaagaact cttctctctg ggggcagagc ttctatttat ggcacataga catcagctag 17640 gcttttggga atcgtttgtg ttctttgtgg aaatgtcctt tagaagcacc catgaagtag 17700 tgtgttcaga ctgtgcacac agaaaacagg ctctgccttc acatgtgaga cggtggactt 17760 ttcctctgga caaaatgaca gcatcctggc gactccacag tggagctgag cgccactccc 17820 tgtagccgat ctgggactga aacgcttaca cctctgcctc agaaggagtc ccccatgccc 17880 tgcctgaaat gacttcactg gacacagcgg ggctgcagct aacggggtac aggtaggagc 17940 taactaactt cacccctgag tccacttgcg gggtaagaga taaacagtaa cccttccagg 18000 agcccactga cgttggagtg ctaaaaatgc cccttcaggg ggaaaactgc attttctctt 18060 ccaaaaagga aaggttcttc caggcgagaa acctgtggtc tagaaccaca gcaagaagag 18120 gaggcatgct ggcctgcacc ggaagactca ctttgtctgc cctgcgccag cctcacctca 18180 ccctgcagtt cccgtttccg ccatggatgc ctcatcacca accctgacct tccccctccc 18240 aaccctttat tcatcctcac tcccactcat acccgcctcc ctggacagtt ccctgctgca 18300 gagttctttc tgctttcagc cctaccttgg tggtgattta cctgaaaatc ttcacaactg 18360 atcattatct ccttctcttt gagacctgac tgaaaaaatt aggtgtgcac acctgtaatc 18420 ccagctacct gggaggctga ggtatgagga ttgcttgagc ctgggagttt gaggctgcag 18480 tgagctatga ttgcaccact gcactccaac ctgggtgaca gagtgagacc ctgtctcaaa 18540 aaaaaataaa ataaggacct tattgtgtgt gcaaattatt tgcctttcat gaatagttat 18600 gagactttgt gcatgtgtta accgagacgg ccctgagcta tttcagttac tcctgtatgt 18660 tcaggcaatt ccaatttaga aacaaacttc cagtgataaa tattgggaag aaaatgtcag 18720 ctcagggcca agtaggtaaa gccacccaag tctagccatg cacacaggca ctagtgtgct 18780 gaaggaaaac acctctgatt tgatacataa agtgtgaagg ttgcataact ggggaggtgg 18840 ctggagaaaa cctgagcctc gagctgagta acaatccaag ccatgattag catttatatt 18900 gcattctgca ttattctcat cctatcacgt tcattaagtt caaccattac cattacgaat 18960 cccgtttcca gctggaaaaa caagcgccag gaaagtgcat ttccccccca cccccccccc 19020 ccaaccagag caactttggt cagaagtcac acctaatcac cctctctgca ggatatgctg 19080 gggatagccc ttttgaggag gtgggggtgt atgcgaaagc aacctggggc caaagcaggg 19140 ggaagcagga gagactggag gggccctggg tccagcaagt gctccaccag gctgcccctg 19200 ctcaggtgct ccacagccca taaaaaacgc cttcagccct gctgtgcttc ccctcacacc 19260 taaacttact ataagggtcc taccttcccc agtattcctt catgatcact gctacctgtg 19320 ccctgaagcg caacagaacc tcaacccaga ggacagccac ttcctcagaa cccacgatct 19380 ttgccccatc gccacaggtc catgagtgac tcctaattac caaatccaag ggctccttca 19440 ccctgaccac tctggaaccc aacaaagctg acacacagcc cagcccagac aggcctgaat 19500 gtgggtcctg gctctcccat ttgccagttc tacagccatg ggcaagtggc tcgacctctc 19560 taagcttcag tttcctcgtc tgtgaaatat ctgtcagtgc tcttaaggga ggagaccacc 19620 ccacatattg tcttacgccc aatttctgcc tccaaagaga gaagtaaaaa ctaaaaggca 19680 gaaatgaaat ccacaagcag acagcctgca ccacaccctg ggcctggtag ttaaagatcg 19740 acgcctgacc taatcagtga tgctatctat agattacaga cattatatag aaaagcaccg 19800 tgaaaatccc tgtcctgttc tgttccgttc taattacggg tgcatgcagc ccccagtcac 19860 gtaccccctg cttgctcaat caatcacgac cctctcacgc agacccctta agagttgtga 19920 gcccttaaaa gggacaggaa ttgctcactc ggggagctca gttgttggag acatgagtct 19980 tgccgaagcg cccggctgaa taaagccctt ctttaactcg tgtctgaggg gttttctctg 20040 cagcttgtcc tgctacattt cttggttccc tgaccaggaa tctaggtgat taatggatgg 20100 ttgaggcagc ccctcagacg gcttaggcct gccctgtgga gcatccctgt ggaggactcc 20160 agccagcttg agcgacatgg atcctgagag cgctctcagg caggcaattg ccccagtgga 20220 atgcctggcc agagcagtgt gtagcaggcc cccgaggagg atcaacgcag tggctgaaca 20280 ccgggaagga actgccactt ggagtccaga catctgaaac ttggtaagac tggtctttgg 20340 aacttgccca ctccatttga ggggaagcgt ggcctgatca cccacggcgt gcctgtactg 20400 gcactctggt ttttgttttt gacttgactt ggattgcttg atactttggt tttggttttg 20460 acctgacttg gatatcctga tactctgatt ttggttttga ttttggtttg gtgtaaactg 20520 taaaagtgtg tgtgtgccct ttttacctgt tctttgtttt gtggtatgcg tgtagggtga 20580 gcgtaatgtt ttgtcttgaa gaagcatggg tcaagcacaa agtaagacca ccccactagg 20640 aactatgctg aaaaatttca ggaaaggatt taagggagac tatggagtac tatgacacca 20700 ggaaaactta aaactttgtg taagatagac tggccagcat tagaggtagg ttggccatca 20760 gagtgaagcc tggacaggtc ccttgtttca aaggtatggc acaaggtaac ctgtaagcca 20820 gt; cccgcccgcc ccaacagtgg ttgagagaac agcagcataa gtggctggca gaggcaagga 20940 aagaccagca gagagagaaa gaggaagaga cagacaaaga gggagtcaga gagagagaga 21000 gaaagagaca gaggcaaaag gaaagtcaaa gagaaagaga cagaaaatca agaggaaaaa 21060 aa 21062 <210> 6 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> RNF213-CF primer <400> 6 actgggtggt cttcccttct 20 <210> 7 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> RNF213-CR primer <400> 7 gaaggagtga gccgagtttg 20 <210> 8 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> F1 primer <400> 8 agcaagttga atacagctcc attaa 25 <210> 9 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> F2 primer <400> 9 agcaagttga atacagctcc attaaa 26 <210> 10 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> F3 primer <400> 10 gcaagttgaa tacagctcca tgaa 24 <210> 11 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> F4 primer <400> 11 caagttgaat acagctccaa caa 23 <210> 12 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> F5 primer <400> 12 caagttgaat acagctccac caa 23 <210> 13 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> F6 primer <400> 13 caagttgaat acagctccag caa 23 <210> 14 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> R1 primer <400> 14 ccctatgcag tgatcctttc g 21 <210> 15 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> ZEN probe <400> 15 accaggactg tcccgcattt ggc 23 <210> 16 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> RNF213_Zen F1 primer <400> 16 cagttccaga acgtccagca a 21 <210> 17 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> RNF213_Zen F2 primer <400> 17 gttccagaac gtccagcaa 19 <210> 18 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> RNF213_Zen R1 primer <400> 18 tttcgaaccg ccaaatgc 18 <210> 19 <211> 27 <212> DNA <213> Artificial Sequence <220> &Lt; 223 > RNF213 (ZEN-A1) probe <400> 19 aatacagctc catcaaaggc ttcctca 27 <210> 20 <211> 23 <212> DNA <213> Artificial Sequence <220> &Lt; 223 > RNF213 (ZEN-A2) probe <400> 20 cagctccatc aaaggcttcc tca 23 <210> 21 <211> 27 <212> DNA <213> Artificial Sequence <220> &Lt; 223 > RNF213 (ZEN-G1) probe <400> 21 ttgaatacag ctccatcaga ggcttcc 27 <210> 22 <211> 20 <212> DNA <213> Artificial Sequence <220> &Lt; 223 > RNF213 (ZEN-G2) probe <400> 22 cagctccatc agaggcttcc 20

Claims (14)

RNF213(Ring finger protein 213) 유전자의 c.14429G>A 돌연변이 검출용 프라이머 및 프로브를 포함하는, RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 조성물로서,
상기 프라이머는 서열번호 1 및 2의 프라이머 쌍이며,
상기 프로브는 서열번호 3 및 4의 프로브 쌍이며,
상기 프로브는 5'-말단에 형광물질로 표지되고, 3'-말단에 소광물질로 표지되며,
상기 프로브 쌍은 RNF213 유전자의 야생형에 결합하는 야생형 검출용 프로브와 RNF213 유전자의 돌연변이에 결합하는 돌연변이 검출용 프로브로 이루어진 것이고,
상기 야생형 검출용 프로브와 돌연변이 검출용 프로브는 상이한 형광물질에 의해 표지되는 것이고,
상기 RNF213 유전자의 돌연변이는 실시간 중합효소연쇄반응에 의해 검출되는 것이고,
상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병은 모야모야병, 뇌혈관 협착증, 뇌혈관 동맥경화증, 신장동맥 협착증 또는 폐동맥 혈관병증인 것인 조성물.
A composition for diagnosing a disease caused by mutation c.14429G > A of RNF213 gene, comprising a primer and a probe for detecting c.14429G > A mutation of RNF213 (Ring finger protein 213) gene,
The primers are the primer pairs of SEQ ID NOS: 1 and 2,
Wherein said probe is a probe pair of SEQ ID NOS: 3 and 4,
The probe is labeled with a fluorescent substance at the 5'-end, a small mineral substance at the 3'-end,
The probe pair is composed of a wild type detecting probe which binds to the wild type of the RNF213 gene and a mutation detecting probe which binds to the mutation of the RNF213 gene,
The wild type detecting probe and the mutation detecting probe are labeled with different fluorescent materials,
Mutations of the RNF213 gene are detected by real-time PCR,
Wherein the disease caused by the c.14429G > A mutation of the RNF213 gene is Moyamoya disease, cerebrovascular stenosis, cerebrovascular atherosclerosis, renal artery stenosis or pulmonary vascular disease.
삭제delete 청구항 1에 있어서, 상기 형광물질은 6-FAM, VIC, TET, 6-JOE, HEX, Cy3, 또는 Cy5인 것인 조성물.The composition of claim 1, wherein the fluorescent material is 6-FAM, VIC, TET, 6-JOE, HEX, Cy3, or Cy5. 청구항 1에 있어서, 상기 소광물질은 MGB-NFQ, 6-TAMRA, BHQ-1, BHQ-2, BH3-3, 또는 ROX인 것인 조성물.The composition of claim 1, wherein the minerals are MGB-NFQ, 6-TAMRA, BHQ-1, BHQ-2, BH3-3, or ROX. 삭제delete 삭제delete 청구항 1, 3 및 4 중 어느 하나의 조성물을 포함하는 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병을 진단하기 위한 키트로서, 상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병은 모야모야병, 뇌혈관 협착증, 뇌혈관 동맥경화증, 신장동맥 협착증 또는 폐동맥 혈관병증인 것인 키트.A kit for diagnosing a disease caused by a mutation of c.14429G > A of the RNF213 gene comprising the composition of any one of claims 1, 3 and 4, wherein the disease causing c.14429G> A mutation of the RNF213 gene Wherein the disease is Moyamoya disease, cerebrovascular stenosis, cerebrovascular atherosclerosis, renal artery stenosis or pulmonary vascular disease. 삭제delete 실시간 중합효소연쇄반응에 의해 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병의 진단에 필요한 정보를 제공하는 방법으로서,
검체로부터 분리된 DNA를 주형으로, 서열번호 1 및 2의 프라이머 쌍, 및 서열번호 3 및 4의 프로브 쌍을 이용하여 실시간 중합효소연쇄반응을 수행하는 단계; 및
RNF213 유전자의 c.14429G>A 돌연변이 부위의 유전자형을 확인하는 단계를 포함하고,
상기 프로브는 5'-말단에 형광물질로 표지되고, 3'-말단에 소광물질로 표지되며,
상기 프로브 쌍은 RNF213 유전자의 야생형에 결합하는 야생형 검출용 프로브와 RNF213 유전자의 돌연변이에 결합하는 돌연변이 검출용 프로브로 이루어진 것이고,
상기 야생형 검출용 프로브와 돌연변이 검출용 프로브는 상이한 형광물질에 의해 표지되는 것이고,
상기 RNF213 유전자의 c.14429G>A 돌연변이를 원인으로 하는 질병은 모야모야병, 뇌혈관 협착증, 뇌혈관 동맥경화증, 신장동맥 협착증 또는 폐동맥 혈관병증인 것인 방법.
As a method for providing information necessary for diagnosing a disease caused by mutation c.14429G > A of RNF213 gene by real-time PCR,
Performing a real-time PCR using the DNA isolated from the sample as a template, the pair of primers of SEQ ID NOS: 1 and 2, and the pairs of probes of SEQ ID NOS: 3 and 4; And
Confirming the genotype of the c.14429G > A mutation site of the RNF213 gene,
The probe is labeled with a fluorescent substance at the 5'-end, a small mineral substance at the 3'-end,
The probe pair is composed of a wild type detecting probe which binds to the wild type of the RNF213 gene and a mutation detecting probe which binds to the mutation of the RNF213 gene,
The wild type detecting probe and the mutation detecting probe are labeled with different fluorescent materials,
Wherein the disease caused by the c.14429G > A mutation of the RNF213 gene is Moyamoya disease, cerebrovascular stenosis, cerebrovascular arteriosclerosis, renal artery stenosis or pulmonary vascular disease.
삭제delete 청구항 9에 있어서, 상기 RNF213 돌연변이 부위의 유전자형을 확인하는 단계에서 상기 RNF213 돌연변이 부위에 대한 야생형 검출용 프로브 신호와 돌연변이 검출용 프로브 신호의 동시 검출은 상기 검체가 이형접합자라는 것을 나타내는 것인 방법.The method according to claim 9, wherein simultaneous detection of the wild type detection probe signal and the mutation detection probe signal for the RNF213 mutation site in the step of identifying the genotype of the RNF213 mutation site indicates that the specimen is a heterozygote. 청구항 9에 있어서, 상기 형광물질은 6-FAM, VIC, TET, 6-JOE, HEX, Cy3, 또는 Cy5인 것인 방법.The method of claim 9, wherein the fluorescent material is 6-FAM, VIC, TET, 6-JOE, HEX, Cy3, or Cy5. 청구항 9에 있어서, 상기 소광물질은 MGB-NFQ, 6-TAMRA, BHQ-1, BHQ-2, BH3-3, 또는 ROX인 것인 방법.10. The method of claim 9, wherein the minerals are MGB-NFQ, 6-TAMRA, BHQ-1, BHQ-2, BH3-3, or ROX. 삭제delete
KR1020160144478A 2016-11-01 2016-11-01 Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof KR101922598B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160144478A KR101922598B1 (en) 2016-11-01 2016-11-01 Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160144478A KR101922598B1 (en) 2016-11-01 2016-11-01 Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof

Publications (2)

Publication Number Publication Date
KR20180047774A KR20180047774A (en) 2018-05-10
KR101922598B1 true KR101922598B1 (en) 2018-11-27

Family

ID=62185177

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160144478A KR101922598B1 (en) 2016-11-01 2016-11-01 Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof

Country Status (1)

Country Link
KR (1) KR101922598B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020092660A (en) * 2018-12-13 2020-06-18 国立研究開発法人国立循環器病研究センター Methods for predicting onset risk of brain infarction
JP2021069346A (en) * 2019-10-31 2021-05-06 義知 本田 Blood vessel aging prediction method, disease risk prediction method, biomarker for predicting vascular aging, biomarker for diseases, measurement kit, and diagnostic device
JP2021090390A (en) * 2019-12-11 2021-06-17 国立研究開発法人国立循環器病研究センター Brain infarction risk evaluation method
CN114182003A (en) * 2022-01-11 2022-03-15 杭州百迈生物股份有限公司 Kit for CYP3A5 polymorphic site genotyping detection and detection method thereof
WO2023153562A1 (en) * 2022-02-14 2023-08-17 주식회사 세니젠 Real-time pcr kit capable of detecting genotype associated with 2'-fucosyllactose production

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100527793B1 (en) * 2004-06-07 2005-11-09 Kogene Biotech Co Ltd Probe for detecting hanwoo and method of detecting hanwoo using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100527793B1 (en) * 2004-06-07 2005-11-09 Kogene Biotech Co Ltd Probe for detecting hanwoo and method of detecting hanwoo using the same

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Environ Health Prev Med, Vol.18, pp.121-129 (2013)
Environmental Health and Preventive Medicine, Vol.21, pp.387-390 (2016.06.30.)*
J Korean Neurol Assoc, Vol.32, No.2, pp.117-120 (2014)
NCBI Reference sequence: NM_001256071.2 (2014.03.25.)*
PLoS ONE, Vol.11, Issue 6, Article e0156607 (2016.06.02.)
PLoS ONE, Vol.6, Issue 7, Article e22542 (2011)
PLoS ONE, Vol.7, Issue 10, Article e48179 (2012)
Scientific Reports, Vol.5, Article 13191 (2015)

Also Published As

Publication number Publication date
KR20180047774A (en) 2018-05-10

Similar Documents

Publication Publication Date Title
KR101922598B1 (en) Composition for diagnosing diseases caused by mutation of RNF213 gene using Real-Time PCR, and use thereof
KR20090056921A (en) Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
KR101206029B1 (en) Multiple SNP for diagnosing colorectal cancer, microarray and kit comprising the same, and method for diagnosing colorectal cancer using the same
KR101206028B1 (en) Method for diagnosing a breast cancer using a breast cancer specific polymorphic sequence, polynucleotide specific to a breast cancer and microarray immobilized with the polynucleotide
KR100754398B1 (en) Multiple SNP for diagnosing cardiovascular disease microarray and kit comprising the same and method for diagnosing cardiovascular disease using the same
JP4926079B2 (en) Breast cancer-related polynucleotide containing single nucleotide polymorphism, microarray and diagnostic kit containing the same, and method for diagnosing breast cancer using the same
JP4889258B2 (en) Method for determining resistance to the onset of bovine leukemia
EP1716255A2 (en) A polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide
KR102115941B1 (en) Single nucleotide polymorphism for predicting the risk factor of metabolic syndrome and the use thereof
KR20130057760A (en) Brca1 and brca2 germline mutations useful for predicting genetic predisposition of breast cancer or ovarian cancer
KR101667189B1 (en) Detection of mutations in ATP7B gene using Real-Time PCR
KR101138863B1 (en) A polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide
US20030152936A1 (en) Compositions and methods for genetic analysis of polycystic kidney disease
KR101754076B1 (en) Method and kit for genotyping HLA-DRB1 and HLA-DRB3/4/5 using real-time PCR
KR101728023B1 (en) Detection of mutations in ATP7B gene using PCR-LDR
KR102115938B1 (en) Single nucleotide polymorphism for predicting the risk factor of metabolic syndrome and the use thereof
KR102115911B1 (en) Single nucleotide polymorphism for predicting metabolic syndrome with nonalcoholic fatty liver disease and the use thereof
CA2461106C (en) Compositions and methods for genetic analysis of polycystic kidney disease
KR101982757B1 (en) Composition, kit for predicting risk of developing hypolipoproteinemia, and method using the same
KR101058583B1 (en) Multiple SNP for Cerebral Infarction, and Microarrays and Kits Comprising the Same
KR20130100075A (en) Brca2 germline mutations useful for predicting genetic predisposition of breast cancer or ovarian cancer
KR101138866B1 (en) Genetic polymorphisms associated with myocardial infarction and uses thereof
JP2004129655A (en) VARIANT OF HNF-1alpha GENE HAVING SINGLE NUCLEOTIDE POLYMORPHISM AND VARIANT OF PROTEIN ENCODED BY THE SAME
JP2008543327A (en) Genetic polymorphisms involved in myocardial infarction and uses thereof
JPH1014585A (en) New oligonucleotide primer and examination of point mutation in exon 4 of human cytochrome p450 2c19 gene using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant